rfhg_225793.1

Basic information about the TSS

---

TSS ID: rfhg_225793.1 Species: human Chr: chr21		Start: 35048801 End: 35048824 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3338012,EH38E2139350)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: U19601:-75 AB384992:-75 GeneID: 861 HGNC/MGI_ID: HGNC:10471 UniProt_ID: Nearer transcript ids and distances: BC110828:-160 KF041488:-214 AK226159:-250 BC136381:-341 BC144053:-341 BC136380:-341 KJ189471:-418 KJ189464:-418 ENST00000416754.1:-446 X90979:-446 AK310587:-463 ENST00000482318.5:-464 D89788:-464 D89789:-464 D89790:-464 ENST00000437180.5:-474 ENST00000455571.5:-474 ENST00000675419.1:-478 NM_001754.5:-478 view more...

Gene_name: RUNX family transcription factor 1 Gene_symbol: RUNX1 Gene_synonyms: AMLCR1 PEBP2A2 Gene_source: HGNC:10471

TATA-Box annotation

---

Distance to TSS:	486
Nearest PromoterID:	NM_001754
Entrez ID:	861
Nearest Unigene:	Hs.149261
Nearest Refseq:	NM_001754
Nearest Ensembl:	ENSG00000159216
Gene Name:	RUNX family transcription factor 1
Gene Alias:	AML1|AML1-EVI-1|AMLCR1|CBF2alpha|CBFA2|EVI-1|PEBP2aB|PEBP2alpha
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.333333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RUNX1 p2@RUNX1 p3@RUNX1 p4@RUNX1 p5@RUNX1 p6@RUNX1 p7@RUNX1 p8@RUNX1 p9@RUNX1 p10@RUNX1
Sample		p1@RUNX1	p2@RUNX1	p3@RUNX1	p4@RUNX1	p5@RUNX1	p6@RUNX1	p7@RUNX1	p8@RUNX1	p9@RUNX1	p10@RUNX1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	44.80	0.00	0.58	0.78	1.17	0.39	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	38.24	0.20	0.00	0.81	2.23	0.61	0.40	0.00	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	37.42	0.00	0.19	1.16	1.16	0.19	0.19	0.00	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	40.75	0.00	0.42	0.62	2.29	0.83	0.21	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.54	0.00	0.22	0.67	2.25	0.67	0.00	0.00	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	41.09	0.19	0.00	0.97	1.74	0.58	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.54	0.00	0.44	0.87	1.31	0.22	0.00	0.00	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.36	0.00	0.73	0.00	1.94	0.24	0.00	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.36	0.00	0.43	0.64	1.28	0.21	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	30.14	0.58	1.16	2.90	1.16	0.58	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	29.91	0.00	0.00	0.81	0.00	0.40	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	28.46	0.00	0.00	1.22	0.00	0.41	0.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.80	11.44	0.00	0.16	2.10	0.16	0.16	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.03	7.67	0.00	0.00	1.50	0.15	0.00	0.30	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.08	10.98	0.22	0.00	1.54	0.00	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.86	12.57	0.25	0.00	2.51	0.25	0.25	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	15.29	9.61	0.00	0.00	2.18	0.22	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	13.08	0.00	0.00	0.42	0.00	1.27	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	7.46	0.00	0.00	3.73	0.53	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.50	9.93	0.30	0.00	1.05	0.00	0.15	0.15	0.45	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.41	10.83	0.13	0.00	1.87	0.40	0.13	0.13	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.83	10.70	0.52	0.17	3.11	0.00	0.17	0.00	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.12	9.82	0.52	0.13	1.81	0.39	0.52	0.13	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.55	8.49	0.73	0.24	1.46	0.00	0.24	0.24	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	43.86	9.55	0.26	0.26	3.10	0.26	0.00	0.26	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	29.75	11.39	0.63	0.00	2.53	0.00	0.32	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	12.64	0.55	0.00	3.85	0.00	0.00	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	65.54	17.45	1.18	0.00	1.65	0.24	0.94	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	40.38	9.05	0.81	0.16	1.78	0.16	0.81	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	62.43	15.56	0.90	0.36	2.17	0.54	0.36	0.54	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	61.34	19.26	1.05	0.00	3.14	0.42	1.88	0.00	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	69.36	16.02	1.17	0.39	3.13	0.59	1.56	0.39	0.39	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	54.45	12.87	0.00	0.00	1.69	1.27	2.11	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	54.27	36.29	0.49	0.00	1.32	0.66	2.31	0.16	0.49	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	78.72	25.06	1.12	0.00	1.68	0.56	1.12	0.56	0.19	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	86.81	21.46	0.19	0.00	2.49	1.34	0.96	0.77	0.57	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	84.82	29.02	1.43	0.61	2.86	0.00	1.84	0.61	0.41	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	79.39	27.81	0.60	0.40	2.82	0.40	1.41	0.60	0.81	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	71.58	41.87	0.27	1.08	3.51	0.54	1.62	1.08	0.54	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	59.54	42.25	0.96	0.48	3.84	0.48	1.44	1.44	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	63.28	37.64	0.47	0.00	2.12	0.24	1.88	1.65	0.24	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	55.04	48.46	0.15	0.15	2.34	0.44	1.17	0.44	0.59	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	71.70	48.29	0.21	0.00	3.59	0.63	1.27	0.84	0.21	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	67.13	49.30	1.05	0.00	2.27	0.17	1.22	0.52	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	66.46	57.02	0.20	0.20	2.81	0.60	1.20	1.61	0.20	3.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	44.67	55.60	0.70	0.23	3.02	0.47	0.47	0.93	0.93	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	51.34	50.62	0.00	0.00	2.40	1.44	1.68	0.00	0.24	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.96	45.01	0.60	0.00	1.79	0.30	0.60	0.60	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.70	56.73	0.00	0.24	2.63	1.20	0.72	1.20	0.00	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	44.48	61.87	0.40	0.00	1.82	0.20	1.01	0.40	0.20	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	78.09	77.47	0.41	0.20	2.87	0.41	0.82	1.23	0.61	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	93.40	76.50	0.22	0.22	2.45	0.44	0.67	1.33	0.22	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	293.84	13.99	0.00	0.00	0.00	0.00	0.00	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	112.14	62.10	0.35	0.00	0.71	0.71	0.00	0.71	0.35	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	119.63	54.35	0.00	0.33	3.65	0.66	0.66	0.00	0.33	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	28.52	219.80	2.52	0.00	2.52	1.68	0.84	1.68	0.00	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	36.28	115.73	0.00	0.46	0.00	0.92	0.92	0.92	0.92	5.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	142.61	59.64	0.00	0.00	0.65	0.65	0.97	0.97	0.32	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	139.07	52.67	0.00	0.32	4.18	0.00	0.00	0.96	0.32	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	72.30	123.53	0.31	0.00	2.83	0.00	0.63	2.51	0.31	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	135.37	58.52	0.00	0.00	0.71	0.71	0.71	0.00	0.71	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	108.23	49.91	0.00	0.00	2.24	0.56	0.00	0.56	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	57.32	198.24	1.59	1.59	0.80	2.39	0.80	2.39	0.80	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	68.97	123.00	1.02	0.00	2.04	0.68	1.02	1.02	0.34	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	136.47	84.15	0.32	0.97	0.97	0.97	1.30	0.65	0.00	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	111.82	59.28	0.35	0.35	0.71	0.35	0.71	0.71	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	323.28	0.00	0.00	0.00	0.00	16.16	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	379.08	7.90	0.00	0.00	7.90	7.90	7.90	0.00	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	76.05	43.39	0.00	0.00	0.49	0.49	0.98	0.00	0.49	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	78.84	55.54	0.00	0.00	2.48	0.00	0.50	0.00	0.50	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	85.85	46.44	0.00	0.00	1.41	0.47	0.00	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.01	52.33	0.00	0.00	0.33	0.00	0.00	0.66	0.33	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	72.08	34.96	0.00	0.00	0.62	0.93	1.24	0.62	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	68.18	35.77	0.00	0.00	1.53	0.61	0.31	0.61	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	32.94	0.32	0.48	1.43	2.22	0.63	0.48	0.00	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	27.11	0.16	0.64	1.28	1.44	0.64	0.80	0.00	0.96	0.00
Adipocyte - omental, donor1	11473-119C6	29.39	0.13	1.53	1.53	1.40	1.27	0.89	0.00	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	11.96	0.00	0.00	0.75	1.49	0.75	2.24	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	11.05	0.33	0.33	1.00	0.33	0.00	3.68	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	12.76	0.00	0.00	0.64	0.00	0.64	2.55	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	2.20	0.00	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	16.26	0.45	0.90	0.00	0.45	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	19.81	0.00	0.52	0.35	0.87	0.87	0.00	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	172.69	18.77	1.56	4.50	5.87	2.35	2.93	0.00	0.98	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	190.46	7.72	1.80	6.43	3.09	4.63	1.54	0.00	3.35	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	78.61	1.95	0.84	2.23	3.62	0.84	1.67	0.28	1.12	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	99.34	1.18	0.59	4.11	5.88	0.59	1.76	0.00	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	41.99	1.61	0.40	1.29	2.01	0.56	0.64	0.00	0.48	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	86.82	9.04	1.61	3.23	3.23	1.94	2.90	0.00	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	42.12	2.13	1.60	1.07	0.00	1.07	1.07	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	32.27	2.23	0.00	0.56	2.78	0.00	0.56	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	24.54	0.00	0.00	0.42	1.25	0.00	1.25	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	57.52	3.01	0.75	1.51	1.26	1.51	1.00	0.00	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	33.38	0.65	0.33	0.98	0.33	0.00	0.00	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	0.00	0.00	0.30	1.22	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	31.38	0.88	3.31	4.64	0.44	1.99	0.44	0.00	1.10	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	13.98	0.36	0.36	0.72	1.79	0.36	2.15	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	0.00	1.20	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	44.98	0.00	1.08	3.60	2.52	1.08	0.00	0.00	1.62	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	0.00	1.67	1.67	1.67	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	31.23	0.21	0.41	3.08	3.08	0.82	0.41	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	20.71	3.20	2.17	4.58	1.14	1.60	0.11	0.00	0.69	0.00
Anulus Pulposus Cell, donor2	11463-119B5	19.35	2.94	0.00	2.45	1.96	1.22	4.65	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.52	0.90	0.45	0.45	0.45	0.90	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.80	0.43	2.60	0.87	2.60	1.30	0.87	0.00	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	0.00	0.00	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	21.82	0.60	1.79	1.20	2.09	0.90	0.90	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	3.79	2.53	2.53	1.26	2.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	0.00	1.32	1.32	0.00	0.66	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.52	0.32	1.30	1.95	1.30	0.32	0.65	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	30.10	1.94	0.49	0.49	1.46	1.94	1.46	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	0.59	2.38	1.19	0.59	1.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.20	1.51	2.64	0.75	1.13	3.01	1.13	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	0.00	1.45	2.18	0.73	2.90	1.45	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	21.31	0.00	0.00	1.25	0.00	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.96	0.49	3.46	1.65	1.81	1.32	0.33	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	1.36	1.36	2.73	2.73	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.56	0.90	2.11	1.66	1.21	1.81	0.15	0.00	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	0.00	1.07	1.61	0.00	0.54	2.68	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	22.67	0.19	2.08	2.65	0.94	2.08	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.65	1.07	2.14	2.94	0.80	1.34	0.53	0.00	0.80	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.98	0.98	1.95	1.95	0.00	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.08	1.16	1.16	1.16	1.49	1.00	1.00	0.17	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	2.40	2.40	0.00	1.20	1.20	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.70	0.17	1.20	2.57	0.34	0.34	1.20	0.00	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	4.19	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.90	0.49	2.91	0.97	0.49	0.97	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.32	0.38	2.28	0.76	0.38	0.38	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	0.00	0.00	1.21	0.00	2.42	1.21	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	1.14	2.28	0.00	2.28	1.71	0.00	0.00	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	18.81	0.64	1.50	1.92	1.07	0.86	2.14	0.00	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	14.71	1.29	1.29	0.77	0.52	0.77	0.00	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	19.24	0.47	0.94	1.88	0.94	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.54	0.32	0.64	1.93	0.64	0.32	1.29	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	0.71	0.71	1.43	1.43	0.00	1.43	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	0.00	1.17	1.17	0.00	0.00	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.76	1.51	1.81	1.20	2.11	0.60	1.20	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	30.89	0.00	2.38	2.38	2.38	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	0.00	3.05	1.53	0.51	0.51	0.00	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.16	0.51	2.55	2.04	1.53	2.04	1.78	0.25	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	0.00	0.64	1.91	0.64	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.85	0.86	0.00	1.73	0.43	0.86	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.90	0.21	0.85	1.48	0.42	1.06	0.64	0.00	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.92	0.58	0.87	0.87	0.87	1.16	0.58	0.00	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.00	0.00	0.00	1.89	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.12	0.51	0.68	1.19	1.02	0.51	1.53	0.00	0.68	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	0.00	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	0.00	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	26.16	0.64	1.07	1.72	1.72	0.64	0.43	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.26	0.60	1.20	0.60	0.00	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.95	2.19	2.19	0.00	1.46	2.92	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.39	0.23	2.30	0.92	1.15	2.76	0.92	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	0.00	5.10	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.78	0.00	2.54	2.54	1.53	0.76	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	18.79	0.62	1.86	1.45	1.45	1.03	1.03	0.00	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.75	1.53	1.53	1.22	0.00	0.61	0.00	0.00	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	0.00	1.43	1.91	0.00	0.96	0.48	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.84	0.44	1.33	1.33	0.44	2.22	0.89	0.00	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	0.00	1.53	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	1.11	2.22	1.66	1.11	2.22	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.12	1.06	1.59	2.12	0.79	2.65	0.53	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	20.35	0.00	0.73	2.18	0.73	1.09	0.36	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	19.65	0.61	0.49	5.16	0.37	0.61	5.53	0.37	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	18.66	1.20	0.00	3.77	1.37	0.34	2.91	0.34	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	13.21	1.68	0.21	3.15	1.05	0.42	0.63	0.21	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	19.52	5.93	0.70	2.09	2.44	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	49.34	12.62	0.32	2.59	1.46	0.16	0.16	0.16	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	51.46	6.86	0.00	2.83	1.64	0.15	0.30	0.15	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.46	0.23	0.00	0.11	0.00	0.00	0.00	0.11	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.38	0.00	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.34	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.34
Basophils, donor1	12241-129G9	100.17	40.54	25.37	3.40	3.66	7.85	0.26	13.08	3.66	7.32
Basophils, donor2	12242-129H1	57.73	33.19	29.95	0.72	3.61	9.74	0.36	31.03	3.25	7.58
Basophils, donor3	12243-129H2	112.31	29.69	53.07	7.35	5.00	13.82	3.09	4.85	5.59	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	13.37	0.00	0.65	1.08	0.86	0.43	0.22	0.00	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	9.60	0.00	0.91	0.91	0.46	0.00	2.74	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	26.36	0.00	0.63	0.00	1.26	0.63	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	18.72	0.00	0.21	0.42	2.08	1.25	2.08	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	28.33	0.00	0.69	1.84	2.76	2.07	5.30	0.00	1.15	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	17.09	0.00	0.54	0.36	1.08	1.26	0.00	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.21	68.53	0.00	0.00	0.41	0.00	0.00	1.75	0.00	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	1.86	17.47	0.00	0.23	3.26	0.00	0.00	4.89	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	149.97	85.38	0.32	0.64	4.80	0.32	1.28	5.76	1.28	5.76
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	124.10	0.00	0.00	20.68	10.34	0.00	10.34	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	165.69	68.19	33.81	3.94	5.07	7.89	2.25	5.07	1.13	6.20
CD14+ Monocytes, donor2	11305-117B9	198.78	51.41	28.77	5.38	4.83	12.06	3.90	6.12	3.16	5.01
CD14+ Monocytes, donor3	11381-118B4	167.51	42.37	19.54	3.95	2.85	8.56	1.98	7.68	1.54	3.73
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	36.51	3.96	1.70	5.09	2.26	0.28	0.85	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	37.91	5.69	0.38	3.41	1.90	0.38	0.38	1.90	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.86	3.62	2.30	3.62	0.99	0.99	0.66	0.00	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	130.09	49.15	35.27	9.68	2.31	6.65	2.02	1.01	2.31	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	162.04	37.72	39.53	14.18	1.81	10.26	0.30	0.30	4.53	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	160.85	50.22	27.01	7.58	3.08	3.79	1.42	0.95	4.03	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	168.40	34.65	21.26	5.52	1.34	6.86	2.85	0.33	3.52	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	197.35	35.61	22.36	6.62	1.10	5.52	3.31	0.55	2.48	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	234.04	51.32	33.97	4.46	2.98	10.17	1.98	0.50	5.70	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	313.87	65.98	84.00	13.90	2.35	29.57	5.29	2.35	7.24	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	321.73	88.85	91.16	16.02	2.85	26.35	5.88	1.60	8.37	2.31
CD14+ monocytes - treated with BCG, donor3	11880-125C8	301.20	126.44	129.93	10.45	3.48	27.86	1.96	2.39	11.75	3.70
CD14+ monocytes - treated with Candida, donor1	11868-125B5	187.07	32.54	20.13	2.81	1.87	5.62	4.68	1.64	1.64	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	236.03	42.77	25.87	4.22	0.00	7.39	4.22	1.58	3.17	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	186.37	42.16	18.86	0.00	0.00	5.55	1.11	1.11	3.33	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	157.82	37.63	32.43	11.16	2.23	10.26	3.27	0.59	2.23	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	160.44	29.73	39.31	10.98	0.80	9.18	1.20	1.00	2.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	123.67	44.14	32.48	5.41	1.46	7.70	0.62	0.21	3.54	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	241.83	35.00	43.01	8.01	1.37	16.24	6.41	0.92	5.03	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	177.34	41.17	52.71	7.46	1.58	13.12	1.36	0.90	3.17	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	226.09	41.90	19.20	4.80	0.00	9.60	3.93	0.87	3.06	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	193.94	50.03	66.98	19.37	2.42	15.87	6.19	1.34	5.11	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	274.77	87.75	103.11	21.11	4.54	24.60	5.76	2.27	8.37	3.31
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	249.97	93.42	75.75	14.31	2.95	18.10	3.79	2.10	6.73	4.63
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	245.99	20.58	40.97	3.86	0.73	11.57	3.31	0.73	2.76	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	244.82	15.50	29.24	7.05	0.70	6.34	1.06	0.70	4.23	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	275.08	27.64	25.88	7.46	1.75	9.65	3.07	0.00	2.63	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	317.01	71.14	105.84	21.10	2.96	28.60	7.15	0.70	8.20	1.92
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	336.00	85.11	107.04	13.75	2.60	28.99	3.72	1.86	11.52	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	351.35	144.20	174.60	9.48	3.45	41.39	3.02	2.80	13.36	2.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	177.72	18.02	21.70	5.32	1.23	8.60	4.91	0.41	2.46	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	180.57	29.44	34.31	3.94	0.93	12.29	1.16	0.23	2.78	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	164.02	31.32	25.06	1.86	0.70	7.66	1.39	0.23	2.09	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	12.86	18.53	1.53	0.65	2.18	0.22	0.87	0.22	0.87	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	18.48	21.48	4.62	0.23	3.00	1.39	0.46	0.23	0.69	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	20.36	18.63	3.68	1.73	2.38	0.87	0.87	2.17	0.43	1.30
CD14+CD16- Monocytes, donor1	11788-124B6	36.13	60.73	7.63	2.96	2.80	2.02	1.56	2.18	1.40	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	22.88	47.68	6.29	1.92	3.49	2.10	1.22	1.75	1.05	3.14
CD14+CD16- Monocytes, donor3	11910-125G2	42.81	69.79	7.80	3.12	3.57	2.23	2.01	2.23	0.89	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	8.68	13.27	0.00	1.28	4.59	0.00	1.79	0.26	0.26	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	7.47	15.81	0.22	0.22	6.15	0.00	0.88	0.66	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	10.11	14.11	0.21	0.84	5.26	0.21	1.47	0.42	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	38.61	0.00	0.00	0.00	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.68	42.03	0.00	0.00	0.68	0.00	0.00	2.03	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	38.32	0.00	0.00	0.00	0.00	0.00	2.07	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	5.86	55.97	0.00	0.00	0.53	0.00	0.00	2.67	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.54	47.71	0.00	0.00	0.54	0.00	0.00	3.22	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.70	39.31	0.00	0.00	0.70	0.00	0.00	2.81	0.00	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	42.36	0.00	0.00	0.00	0.00	0.00	0.78	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	54.05	0.00	0.00	0.00	0.00	0.00	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	18.08	58.35	0.82	0.82	0.82	0.82	0.00	6.58	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	14.51	48.60	0.00	0.00	0.00	0.73	0.73	2.90	1.45	2.18
CD19+ B Cells, donor3	11705-123B4	14.14	57.05	0.50	0.00	0.50	1.01	0.50	2.02	0.50	3.53
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	20.20	0.81	0.40	1.21	0.40	0.00	2.42	0.00	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	19.97	6.39	0.40	0.00	2.00	0.00	0.80	2.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	53.21	88.36	5.02	5.02	2.01	1.00	0.00	7.03	4.02	7.03
CD34+ Progenitors, donor2	11625-122B5	62.36	61.80	3.37	1.12	0.56	2.81	12.36	12.36	2.81	7.30
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	81.54	66.51	0.38	0.75	4.51	0.38	0.00	2.63	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	90.87	73.73	0.00	0.68	4.28	1.13	0.23	2.25	1.13	3.38
CD4+ T Cells, donor1	11225-116C1	10.35	127.47	0.36	0.71	2.50	0.36	0.00	6.07	2.86	9.64
CD4+ T Cells, donor2	11306-117C1	12.86	79.61	1.84	0.00	1.22	1.22	0.61	7.35	1.84	4.90
CD4+ T Cells, donor3	11382-118B5	25.62	100.65	0.91	1.52	0.30	0.61	0.00	7.62	1.52	7.32
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	9.44	73.00	0.26	0.51	0.26	0.26	0.00	3.06	2.04	8.93
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.94	71.87	0.00	0.00	0.22	0.22	0.22	1.80	0.67	7.64
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	5.46	66.98	0.29	1.44	0.57	0.00	0.00	2.01	0.57	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.84	92.92	0.00	0.00	1.42	0.00	0.00	4.27	1.90	8.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	97.62	0.00	0.70	0.00	0.70	0.00	3.51	0.00	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	92.29	0.00	0.00	0.00	0.00	0.00	3.30	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.99	29.19	0.72	2.02	2.17	0.14	0.00	5.20	2.31	9.10
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.56	44.23	0.17	1.36	1.36	0.34	0.34	3.39	1.86	6.27
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.25	31.92	0.16	1.45	0.64	0.00	0.48	4.19	2.26	7.90
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	7.62	65.00	1.79	2.69	0.45	0.00	0.00	6.28	4.93	7.17
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	5.59	74.42	0.70	1.05	0.00	0.35	0.00	6.29	0.70	6.29
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	8.80	102.52	0.44	3.08	1.32	0.44	0.44	5.72	7.48	14.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	68.31	0.42	0.00	1.26	0.00	0.00	5.06	1.26	9.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	8.73	43.22	0.00	0.62	1.04	0.00	0.21	4.16	0.62	4.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	5.68	31.41	0.67	0.33	1.67	0.00	0.00	4.01	0.00	6.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.99	168.60	0.82	0.00	1.36	0.54	0.00	2.45	1.63	9.79
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	199.37	0.00	0.00	1.61	0.00	0.00	3.75	0.00	10.72
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	121.94	0.00	0.00	0.00	0.00	0.00	1.79	0.00	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	17.62	49.14	0.19	2.04	2.41	0.00	0.19	10.20	3.15	11.13
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.69	40.29	0.43	1.30	1.73	0.22	0.87	8.88	4.12	10.18
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	29.42	36.57	0.21	1.89	1.68	0.42	0.63	18.28	2.73	16.18
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.57	82.92	0.00	2.02	1.52	0.00	0.51	12.64	2.02	15.17
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	2.17	93.15	0.00	0.00	0.87	0.00	0.43	8.23	1.30	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	3.92	132.05	0.00	0.00	2.61	0.00	0.00	16.13	2.18	13.51
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1.98	75.22	0.00	0.49	1.48	0.00	0.00	9.90	0.49	8.41
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.92	46.16	0.00	0.92	1.85	0.00	0.00	15.69	0.00	7.39
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	37.69	0.00	1.40	2.79	0.00	0.00	15.35	0.00	5.58
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	4.15	56.49	0.00	0.55	1.11	0.00	0.83	14.68	0.55	8.31
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.66	60.86	0.00	0.00	1.72	0.00	1.23	22.09	0.25	11.29
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	3.08	64.68	0.00	0.00	1.54	1.54	0.00	15.40	0.00	9.24
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.45	73.06	0.36	0.36	0.72	0.72	0.00	17.91	1.07	6.80
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	48.47	0.00	2.77	4.15	0.00	0.00	19.39	0.00	6.92
CD8+ T Cells, donor1	11226-116C2	18.33	36.34	2.62	0.33	2.29	0.98	0.33	27.83	1.96	11.79
CD8+ T Cells, donor2	11307-117C2	29.66	15.77	1.13	1.50	2.63	1.50	0.38	17.65	1.88	10.14
CD8+ T Cells, donor3	11383-118B6	16.41	44.94	1.01	0.50	1.77	0.00	0.00	18.18	0.25	10.60
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.98	2.75	0.00	3.67	2.98	1.38	0.00	0.00	0.92	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.27	4.79	0.24	2.40	2.40	1.20	0.00	0.00	1.92	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.46	2.19	0.27	3.56	2.19	1.37	0.55	0.00	1.64	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	42.33	7.51	1.20	5.40	1.20	2.40	0.30	0.00	3.60	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	42.96	4.32	0.24	6.00	2.88	0.72	0.48	0.24	1.44	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	45.48	4.78	0.45	3.41	2.96	1.14	0.23	0.00	1.82	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	40.63	2.61	0.22	4.35	2.39	1.30	0.65	0.00	3.04	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.06	2.63	0.00	3.95	5.79	1.84	0.26	0.26	2.37	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	42.21	2.58	0.47	3.05	1.64	2.11	0.94	0.00	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	40.15	2.72	0.00	2.42	3.02	2.11	0.60	0.00	2.42	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.31	2.61	0.00	3.20	2.61	1.16	0.29	0.00	2.32	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	53.02	2.66	0.53	2.13	2.66	2.66	0.27	0.00	4.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	137.45	3.94	1.31	5.69	3.06	4.38	0.88	0.00	3.94	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	146.19	5.47	2.28	11.39	3.64	3.64	0.91	0.00	8.20	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	154.40	2.98	1.49	14.17	0.75	3.73	0.00	0.00	4.48	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.50	2.16	0.72	6.84	3.60	1.44	0.36	0.00	2.88	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	47.76	5.47	1.15	6.62	2.01	2.01	0.29	0.00	3.16	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	38.42	4.01	0.24	5.19	2.36	0.94	0.71	0.00	1.41	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	53.24	4.12	0.32	5.39	2.85	2.54	0.32	0.00	3.49	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	40.29	3.08	0.62	4.92	2.15	1.23	0.00	0.00	1.54	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	45.84	2.56	0.32	7.37	0.00	1.28	0.00	0.00	3.53	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	49.72	4.59	0.76	2.68	3.44	1.91	0.00	0.00	1.91	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.53	2.76	0.79	3.55	5.12	1.18	0.39	0.00	1.97	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.80	1.51	0.00	3.03	2.27	0.00	0.76	0.00	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	186.29	5.62	0.00	8.03	4.82	0.80	1.61	0.00	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	163.67	6.99	0.70	8.39	2.10	0.70	1.40	0.70	2.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	202.35	7.01	1.00	10.02	2.00	1.00	1.00	0.00	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	45.69	0.00	0.00	1.83	1.83	0.00	5.48	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.40	0.00	0.00	1.48	1.48	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	3.79	0.00	0.32	0.32	0.42	0.42	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	20.80	0.69	1.39	1.73	1.04	1.73	4.51	0.00	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	32.34	1.07	2.13	3.55	0.36	0.71	0.00	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	41.64	0.68	1.25	3.75	1.59	1.71	0.46	0.00	0.91	0.00
Chondrocyte - re diff, donor2	11339-117F7	170.99	10.74	21.49	20.59	8.06	17.01	2.69	1.79	8.95	1.79
Chondrocyte - re diff, donor3	11411-118E7	170.25	7.28	4.04	8.09	3.64	10.92	1.21	0.00	3.64	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	31.33	4.71	0.69	3.21	0.80	1.61	0.57	0.46	1.49	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	29.71	3.85	0.64	2.35	0.64	0.86	1.07	0.00	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	34.87	3.10	0.27	4.07	1.24	0.35	0.18	0.53	0.71	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.71	4.03	0.18	1.56	1.47	0.28	0.09	1.19	0.55	0.55
Corneal Epithelial Cells, donor1	11526-119I5	22.40	0.22	2.20	2.42	0.88	1.10	0.00	0.00	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.55	0.00	0.00	0.77	1.79	1.02	0.26	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	66.53	13.04	1.16	2.15	1.98	0.33	0.83	0.17	1.16	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	55.20	13.56	1.58	1.89	2.52	0.32	1.58	0.00	0.95	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	69.01	13.80	0.00	0.00	0.00	0.00	3.45	0.00	3.45	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.80	11.88	0.54	1.84	2.05	1.08	0.76	0.43	0.97	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	79.60	33.14	6.49	16.40	3.07	2.05	1.37	3.07	17.42	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	67.25	26.77	0.65	5.88	0.65	0.65	0.00	1.31	0.65	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	33.88	18.39	4.36	11.13	2.90	0.48	11.13	1.45	8.23	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	12.34	0.00	0.00	2.00	0.83	0.00	0.00	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	0.00	0.00	1.76	1.76	0.00	0.00	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	12.44	0.28	0.28	0.28	1.98	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	6.68	0.00	0.00	0.39	0.39	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.73	0.00	0.00	0.87	0.29	0.29	0.00	0.29	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	11.29	0.00	0.24	0.47	0.24	0.00	0.24	0.00	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	18.76	0.35	0.18	0.70	0.53	0.53	0.00	0.00	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	6.21	0.00	0.00	1.11	0.22	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	8.82	0.61	0.61	1.22	0.00	0.00	0.30	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	4.79	0.00	0.00	1.13	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	1.78	0.00	0.00	0.89	0.00	0.59	1.19	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	2.60	0.00	0.00	0.52	0.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.28	0.00	0.00	0.14	0.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	10.40	0.00	0.00	0.40	2.00	0.00	2.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	0.00	0.00	0.00	0.52	1.57	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	8.20	0.00	0.00	1.74	0.87	0.00	0.12	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	4.78	0.00	0.00	0.87	1.09	0.22	0.22	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	9.65	0.12	0.00	1.47	0.98	0.12	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	13.65	0.00	0.00	1.14	2.28	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	0.00	0.00	0.70	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.97	0.00	0.00	0.79	0.31	0.47	0.00	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	18.15	26.40	1.65	0.00	1.65	0.00	1.65	4.95	0.00	13.20
Eosinophils, donor3	12246-129H5	28.53	49.94	0.00	0.00	3.57	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.04	0.24	0.24	1.71	1.71	0.98	0.00	0.00	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	4.16	2.08	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	61.17	22.58	2.46	4.93	0.41	2.87	0.82	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.55	2.19	0.99	1.20	0.77	1.09	0.22	0.00	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.84	0.54	0.43	1.41	1.52	0.43	0.22	0.00	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.74	0.97	1.70	1.58	1.82	1.09	0.24	0.00	0.36	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	91.44	18.83	18.97	13.10	2.18	9.42	1.77	0.82	2.59	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.23	2.95	3.06	3.80	1.48	1.37	0.21	0.11	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.68	1.32	2.90	5.80	2.11	3.69	11.59	0.00	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	28.90	2.66	0.33	3.99	1.33	0.00	0.33	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	10.89	0.00	0.00	0.00	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.22	0.00	0.76	1.52	1.52	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.61	2.84	0.95	0.79	1.10	0.47	0.32	0.32	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	19.70	0.00	0.00	1.21	3.64	0.30	0.00	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	12.94	0.13	0.13	1.02	0.89	0.25	1.27	0.00	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	8.34	0.15	0.30	0.91	0.61	0.30	1.21	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.27	1.34	0.13	1.47	0.80	0.40	1.74	0.27	0.54	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.83	0.86	0.43	1.29	0.86	0.43	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	33.69	5.86	0.00	0.00	2.93	2.93	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	27.22	0.23	0.00	7.61	1.61	0.69	0.00	0.00	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	13.74	0.00	0.34	2.20	0.85	0.34	0.00	0.17	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	11.27	0.47	1.17	0.94	0.94	0.47	0.23	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	13.21	0.00	0.47	3.30	0.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.14	0.00	1.21	0.85	1.57	0.48	0.00	0.00	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	14.36	0.23	0.68	5.65	1.70	0.45	1.81	0.00	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	21.28	0.35	1.57	3.14	1.40	0.35	3.14	0.00	0.70	0.00
Fibroblast - Dermal, donor6	11458-119A9	17.05	0.49	1.79	2.27	1.62	0.81	2.44	0.00	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	15.83	1.04	0.62	1.46	1.25	1.25	0.42	0.00	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.91	4.45	1.31	4.19	3.41	1.31	1.05	0.00	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	23.46	2.24	1.32	2.77	3.82	0.66	0.13	0.00	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	41.77	4.06	0.97	5.12	2.80	1.35	0.10	0.00	0.87	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	4.16	1.04	3.12	1.04	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.49	3.88	0.70	2.29	1.76	0.00	0.53	0.18	0.18	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.97	5.30	2.65	7.02	2.65	2.18	1.25	0.31	0.47	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	19.07	1.49	2.43	3.25	2.03	0.95	0.41	0.00	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	36.35	6.35	2.82	9.88	3.18	1.41	0.71	0.71	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.08	4.83	2.49	4.53	2.78	0.73	0.73	0.15	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.45	4.91	3.14	4.91	2.18	1.50	0.55	0.27	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	43.44	3.51	4.61	4.94	3.29	1.86	0.66	0.00	0.55	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.72	5.43	1.32	2.93	2.93	1.47	0.29	0.29	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	24.47	0.00	1.36	4.08	2.72	4.08	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	0.00	5.97	7.46	1.49	1.49	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	34.40	0.00	1.69	1.27	2.74	1.69	0.84	0.00	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	24.16	0.00	4.17	5.00	2.50	2.50	5.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	0.00	2.80	1.40	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.67	0.84	0.00	0.84	3.08	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	53.18	2.84	5.28	6.90	5.28	3.25	0.41	0.00	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00	3.99	3.99	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.08	2.91	2.33	1.16	2.72	0.97	0.19	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.39	1.67	1.52	5.46	2.28	0.91	0.46	0.00	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.74	3.37	2.75	5.20	1.53	1.22	0.31	0.00	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.13	0.76	0.38	4.20	0.76	0.00	0.00	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	27.27	1.35	1.35	4.59	2.43	1.35	0.27	0.00	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	25.40	3.25	0.46	2.32	1.39	0.35	0.23	0.00	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.48	0.55	1.11	0.88	0.99	0.44	0.11	0.22	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.74	0.20	1.02	4.88	1.83	1.02	0.00	0.00	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	12.03	0.00	0.67	1.34	2.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.07	0.00	0.79	2.37	1.98	0.40	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	41.08	14.09	3.77	12.30	2.58	3.57	15.28	0.20	1.39	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	49.38	10.30	2.13	3.02	3.02	1.42	0.53	0.36	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	68.78	1.97	3.15	3.94	4.73	3.15	1.18	0.00	1.58	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	31.29	5.11	5.11	10.53	2.71	6.32	8.42	0.00	2.11	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	43.18	4.86	4.10	5.72	2.27	4.43	13.82	0.11	2.70	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	29.10	12.65	3.04	8.35	0.76	2.53	9.62	0.00	0.51	1.27
Fibroblast - skin normal, donor1	11553-120C5	35.44	7.38	2.30	2.30	1.80	1.48	0.16	0.49	1.80	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	77.20	8.22	10.63	13.23	7.62	6.02	0.60	0.20	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	30.64	3.82	3.11	4.62	3.32	3.42	6.43	0.60	1.00	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	53.50	16.02	8.76	19.34	4.53	6.95	21.16	0.00	1.51	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	83.84	12.59	2.98	3.40	3.65	2.90	0.66	0.17	1.74	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	11.62	1.03	0.34	2.05	0.68	0.68	3.76	0.00	1.03	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.11	16.09	6.24	14.12	2.30	5.25	8.21	0.00	2.30	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.16	8.63	3.30	4.69	1.81	1.60	4.69	0.53	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	41.16	2.19	3.54	3.88	2.87	1.01	0.17	0.00	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.25	5.49	1.41	0.63	0.63	0.94	0.00	0.00	0.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	22.16	0.00	0.00	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	2.61	0.87	1.74	6.97	1.74	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	33.98	9.19	1.73	1.04	1.91	1.73	1.04	0.17	0.87	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	37.21	17.70	3.38	1.04	1.04	1.56	0.26	0.52	1.04	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	67.46	6.13	2.04	1.28	3.07	3.32	0.26	0.00	1.53	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	3.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	2.55	0.00	0.00	0.00	0.64	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	0.83	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.05	11.42	0.00	0.00	0.46	0.00	0.23	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.76	0.40	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	2.38	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	7.50	0.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1.77	0.00	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	0.57	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	5.54	0.00	0.00	0.12	0.25	0.12	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.05	0.37	0.12	0.87	0.87	0.12	0.12	0.00	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	27.69	0.55	0.55	0.69	0.55	0.28	0.14	0.00	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	17.08	0.20	0.00	0.41	0.61	0.00	0.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.06	0.46	0.46	1.83	1.60	0.46	0.00	0.00	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	24.79	1.37	0.62	0.87	1.12	0.37	0.12	0.00	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.42	0.22	0.44	0.87	1.31	0.22	0.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.39	0.59	0.00	0.59	0.30	0.59	0.30	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	11.76	0.48	0.00	0.48	1.11	0.00	0.00	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	8.27	0.45	0.00	0.22	0.45	0.00	0.67	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.65	0.40	0.20	0.20	0.20	0.00	0.00	0.00	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.50	0.00	0.17	0.34	0.51	0.34	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	13.03	0.89	0.44	1.33	0.80	0.18	0.09	0.00	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.83	0.52	0.10	0.42	1.04	0.21	0.00	0.00	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.66	0.51	0.00	0.51	0.68	0.00	0.00	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	7.30	0.44	0.22	1.00	0.44	0.22	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.16	0.17	0.25	1.00	0.75	0.00	0.00	0.00	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	6.33	0.20	1.43	0.82	0.20	0.20	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	3.71	0.21	0.21	1.03	0.41	0.00	0.00	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.19	0.23	0.00	0.81	0.23	0.12	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.67	0.00	0.33	1.17	0.50	0.00	0.17	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.85	0.44	0.00	0.88	0.66	0.00	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	4.55	0.00	0.12	0.37	0.74	0.12	0.00	0.00	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	7.62	0.00	0.49	0.32	0.81	0.00	0.16	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	2.89	0.00	0.32	0.96	1.60	0.32	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.02	0.00	0.09	0.47	0.76	0.09	0.00	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	4.90	0.32	0.16	0.32	0.79	0.32	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	10.64	0.00	0.30	0.91	0.91	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.45	0.10	0.00	0.42	0.63	0.10	0.10	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	3.95	0.22	0.22	0.66	0.88	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5.61	0.56	0.28	0.28	0.28	0.28	0.28	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	25.74	0.46	0.28	0.56	0.37	0.28	0.19	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.24	0.27	0.80	0.53	1.34	0.00	0.53	0.27	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.79	1.22	0.00	1.38	1.53	0.15	0.31	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.76	0.13	0.39	1.04	1.17	0.26	0.26	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	9.22	0.54	0.00	1.36	1.08	0.27	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.94	0.92	0.37	2.40	1.11	0.74	0.37	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.81	0.44	0.88	1.75	0.44	0.66	0.88	0.00	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	0.00	0.00	6.94	0.99	1.98	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.97	2.37	0.79	1.45	1.58	0.26	0.13	0.00	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.84	1.01	0.81	2.42	2.42	0.81	0.40	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	140.80	0.76	6.10	13.47	3.05	3.81	0.25	0.25	6.35	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	0.60	0.00	0.00	0.00	0.20	0.00	0.20	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	0.62	0.00	0.00	0.00	0.15	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.20	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.09	0.00	0.00	0.00	0.39	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	3.25	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.06	0.00	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	0.00	0.00	0.00	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	2.80	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	3.60	0.00	0.00	0.00	0.33	0.00	0.65	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	0.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1.91	0.00	0.00	0.00	0.64	0.00	0.00	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	0.89	0.00	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	3.31	0.00	0.00	0.41	0.83	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1.38	0.00	0.00	0.00	0.46	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1.92	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	0.00	0.00	0.00	0.33	0.00	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5.14	0.00	0.00	0.34	1.37	0.34	0.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	0.47	0.00	0.00	0.00	0.94	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1.81	0.00	0.00	0.00	1.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1.53	0.00	0.00	0.00	0.51	0.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1.99	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	0.99	0.00	0.00	0.00	0.49	0.00	0.00	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	5.90	1.18	0.00	0.00	0.00	0.00	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1.75	0.00	0.00	0.00	0.58	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1.32	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2.98	0.00	0.00	0.00	0.60	0.00	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.28	0.49	0.00	0.00	0.00	0.00	0.97	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	2.28	2.28	0.00	1.14	3.42	0.00	0.00	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.28	2.08	0.00	2.49	0.42	0.00	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	21.36	0.00	0.00	2.25	4.50	1.12	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.10	6.34	1.27	2.54	0.95	1.59	0.63	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	9.61	9.19	1.67	0.42	0.42	1.25	0.42	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.39	0.70	0.58	0.70	1.97	0.12	0.46	0.12	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.06	0.51	0.17	1.35	1.69	0.51	0.17	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	14.79	1.37	0.23	0.46	0.91	0.46	0.46	0.00	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.88	0.98	0.33	0.87	1.75	0.44	0.33	0.00	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.34	1.29	0.21	0.86	0.86	0.43	0.43	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.30	0.65	0.22	1.29	0.86	0.22	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.46	0.62	0.25	0.87	1.00	0.37	0.50	0.00	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.84	0.86	0.34	0.69	1.20	0.34	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.85	0.96	0.00	0.32	0.32	0.00	0.32	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.80	6.49	0.43	2.16	1.30	0.43	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.04	0.00	0.00	1.06	1.41	0.35	0.00	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	24.70	6.54	0.00	0.73	1.45	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.31	0.00	0.70	1.05	1.75	0.17	0.17	0.00	0.00	0.17
Hepatocyte, donor1	11523-119I2	8.47	0.00	0.00	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	42.02	0.00	0.00	3.23	2.15	0.00	1.08	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	20.25	0.61	0.61	1.23	3.07	0.00	0.61	0.61	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	127.27	131.84	0.65	1.96	3.92	1.96	0.65	4.57	1.31	11.75
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.05	0.17	0.00	1.75	3.67	0.00	0.17	0.00	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.35	1.10	1.92	1.37	0.55	2.06	0.00	0.00	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	3.18	0.00	0.00	15.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	0.00	0.00	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	4.15	0.00	0.00	9.69	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	12.51	0.00	0.00	17.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	10.25	0.00	2.56	5.13	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	9.14	0.00	0.00	22.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	9.75	0.00	3.25	9.75	1.62	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	5.00	0.00	0.00	10.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	21.78	0.00	3.63	10.89	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	13.23	1.32	0.00	6.62	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	28.82	1.11	0.00	0.00	9.98	1.11	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	20.95	0.00	0.00	20.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	28.34	5.67	0.00	0.63	5.04	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	0.00	0.00	0.00	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	42.64	7.11	0.00	0.00	10.34	0.00	0.65	0.65	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	4.83	0.00	0.00	12.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	43.19	5.70	0.00	0.00	10.59	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.07	4.62	0.42	0.00	7.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.95	9.64	0.80	0.00	8.84	0.00	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	33.24	2.77	0.00	0.00	8.31	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.51	3.30	0.00	0.00	3.30	0.00	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	20.86	1.81	0.91	0.00	3.63	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	39.82	2.15	0.00	0.00	5.38	0.00	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	5.08	0.00	1.27	11.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	32.52	6.38	0.00	0.00	6.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	1.82	0.00	1.82	5.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	38.56	5.71	0.00	0.71	7.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	3.32	0.00	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	22.22	4.01	0.00	0.62	6.79	0.00	0.00	0.00	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	1.76	0.00	1.76	7.02	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	36.86	2.09	0.00	0.00	4.17	0.00	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	90.74	11.07	0.00	2.21	22.13	0.00	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	35.66	6.48	0.00	0.00	29.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	90.68	20.05	0.00	2.62	22.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	53.99	11.25	0.00	0.00	11.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	17.42	0.00	0.00	27.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	91.74	14.93	0.00	0.00	24.54	1.07	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	48.49	6.93	0.00	0.00	19.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	8.55	0.00	0.00	17.10	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	62.59	6.44	0.00	0.00	13.81	0.92	2.76	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	81.68	27.23	0.00	3.03	21.18	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	18.63	0.00	6.21	43.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	77.19	10.57	0.00	1.06	19.03	1.06	1.06	0.00	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	32.07	28.15	0.98	0.41	1.31	1.47	0.65	0.24	0.65	0.33
Keratinocyte - epidermal, donor2	11349-117G8	26.94	0.00	1.76	0.59	2.34	0.59	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	50.07	0.00	0.66	0.95	3.69	1.80	0.38	0.00	0.66	0.00
Keratinocyte - oral, donor1	11251-116E9	32.13	0.11	1.93	3.41	2.95	3.97	0.00	0.00	1.14	0.00
Keratocytes, donor1	11527-119I6	27.16	0.69	2.41	7.22	3.09	1.03	0.34	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	16.41	1.17	1.17	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	32.41	1.78	0.20	2.77	2.17	1.78	0.79	0.00	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	180.23	0.00	0.00	0.00	19.78	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	16.18	1.08	1.08	4.31	2.16	0.00	0.00	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.76	2.19	0.69	2.19	0.58	0.46	0.12	0.00	0.58	0.00
Lens Epithelial Cells, donor3	11690-122I7	22.30	2.32	0.61	2.32	1.21	0.50	0.10	0.00	0.40	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2.25	0.00	0.12	0.59	0.36	0.12	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.86	0.00	0.00	1.40	0.28	0.00	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	2.83	0.00	0.00	0.16	0.31	0.00	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	1.08	0.00	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.41	0.00	0.00	1.26	0.32	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.29	0.00	0.00	0.00	0.00	0.00	0.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.34	0.00	0.00	0.00	0.00	0.00	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.06	0.00	0.00	0.51	0.00	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.11	0.00	0.00	0.28	0.14	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	3.56	0.00	0.00	0.40	0.79	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.23	0.00	0.00	1.36	0.78	0.19	0.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.67	0.00	0.19	0.00	0.37	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2.79	0.00	0.00	1.39	0.35	0.00	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.49	0.00	0.00	0.24	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.92	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4.31	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.99	0.00	0.00	0.31	0.62	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1.83	0.00	0.00	0.18	0.55	0.18	0.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	3.29	0.00	0.00	0.99	0.00	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.39	0.00	0.29	1.46	1.17	0.29	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	0.25	0.00	0.00	0.25	0.00	0.00	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	2.91	0.00	0.00	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	3.50	0.00	0.00	1.35	0.54	0.27	0.27	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	1.51	0.00	0.00	0.15	0.15	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.11	0.00	0.00	0.52	0.00	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.70	0.00	0.00	0.84	0.21	0.00	0.00	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	1.20	0.00	0.00	0.00	0.45	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	4.13	0.00	0.69	0.00	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.64	0.00	0.19	1.51	0.38	0.00	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.59	0.00	0.00	0.32	0.21	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	2.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.63	0.00	0.00	0.99	0.66	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.73	0.00	0.00	0.12	0.25	0.00	0.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	3.70	0.00	0.37	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.94	0.00	0.25	0.74	0.49	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.24	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	1.93	0.00	0.00	0.32	0.32	0.00	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.70	0.00	0.00	1.83	0.30	0.30	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1.96	0.00	0.00	0.42	0.14	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	3.20	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	0.00	0.00	0.48	0.00	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.40	0.00	0.00	0.31	0.16	0.00	0.16	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	2.15	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	3.09	0.00	0.25	1.36	0.50	0.00	0.00	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.10	0.00	0.00	0.26	0.51	0.00	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	1.19	0.00	0.00	0.90	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	0.00	0.00	2.27	4.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	37.59	0.00	0.00	2.30	2.30	0.77	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	35.63	0.00	0.74	0.00	3.71	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	41.47	0.00	0.42	1.69	2.54	0.85	2.12	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.87	0.00	0.70	1.41	2.81	0.70	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.03	0.00	0.00	1.87	1.87	0.00	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.98	0.52	0.00	1.55	3.09	2.06	3.09	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	42.82	0.00	0.00	1.19	3.57	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	37.32	0.00	0.23	2.04	2.94	0.90	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	30.83	0.00	0.29	0.58	3.49	0.00	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	42.32	0.00	0.90	0.90	3.60	0.45	0.90	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	58.80	0.14	0.68	2.30	4.06	0.81	1.22	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	50.84	0.00	0.00	1.03	2.05	2.05	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	46.93	0.00	0.35	1.41	1.06	0.35	0.71	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.98	0.00	0.67	2.00	1.33	0.67	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	58.07	0.51	0.00	2.55	2.04	2.04	0.51	0.00	2.55	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	44.56	0.00	0.00	0.53	2.93	0.53	1.07	0.00	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	52.53	0.00	0.38	3.02	3.97	0.94	1.32	0.00	1.89	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	60.74	0.00	0.61	1.84	3.07	1.23	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	57.90	0.82	0.00	1.63	8.97	0.82	0.00	0.00	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	52.06	0.00	0.83	1.04	3.12	1.04	0.42	0.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	45.96	0.00	0.28	2.52	5.04	1.12	1.12	0.00	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	64.91	0.00	1.03	2.06	7.21	0.00	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	57.19	0.00	0.58	2.03	2.90	0.87	0.87	0.00	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	48.43	0.00	0.00	2.69	2.39	0.60	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.69	0.00	0.55	2.21	2.21	0.00	2.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	68.93	0.35	0.71	3.18	2.83	1.77	1.77	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	59.37	0.00	0.37	2.58	4.43	0.74	0.37	0.00	2.58	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	49.50	0.00	0.00	0.00	5.76	0.00	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	56.80	0.38	0.00	3.07	4.22	1.54	0.38	0.00	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.63	0.57	0.57	1.70	2.83	0.57	1.70	0.00	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	53.33	0.00	0.82	1.64	2.46	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	56.03	0.45	0.45	3.62	3.16	1.81	1.81	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	34.47	0.00	1.44	1.44	2.87	1.44	0.72	0.00	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	50.04	0.00	0.75	0.00	4.48	0.00	0.00	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	53.14	0.00	0.37	1.49	5.57	0.74	1.49	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	33.60	0.00	0.43	0.43	1.72	0.00	0.00	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	41.96	0.00	0.00	1.71	8.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	37.98	0.00	0.00	1.00	4.00	0.33	1.33	0.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.61	0.00	0.60	3.02	3.62	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	41.95	0.00	0.00	0.00	3.55	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.75	0.34	0.34	0.69	4.12	0.69	1.03	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	31.13	0.00	0.54	2.15	4.83	0.00	1.07	0.00	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	40.40	0.00	0.00	2.69	5.39	0.67	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	47.04	0.00	0.74	0.74	2.59	0.00	0.74	0.00	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	0.00	0.00	1.16	3.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	0.00	0.00	2.12	3.17	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	39.61	0.40	0.40	4.00	5.20	0.80	1.20	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	48.70	0.00	0.00	0.00	3.63	0.00	0.73	0.00	2.18	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	59.02	0.00	1.53	1.53	6.90	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	51.79	0.49	0.49	2.47	5.43	1.97	0.49	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	49.87	0.94	0.00	1.88	5.65	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	67.88	0.00	0.00	1.51	7.04	0.00	0.50	0.00	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	67.14	0.45	0.45	2.25	5.86	0.45	0.90	0.00	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	46.47	0.00	0.00	1.72	1.72	1.72	0.00	0.00	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	63.68	0.00	0.00	2.23	3.12	1.78	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	86.81	0.00	0.78	1.96	3.91	0.78	0.78	0.00	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.80	0.00	0.00	2.64	2.64	1.98	0.66	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	76.80	0.00	0.00	1.56	6.23	2.08	1.04	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	83.14	0.44	0.44	4.81	3.50	2.63	1.75	0.00	2.63	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	71.01	0.00	1.12	5.03	5.03	1.12	1.12	0.00	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	85.68	0.00	0.44	1.32	5.74	0.88	0.44	0.00	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	77.53	0.39	1.16	1.16	6.94	3.47	2.70	0.00	1.93	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	67.35	0.51	1.01	2.03	3.04	3.54	0.51	0.00	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	92.76	0.00	0.48	0.00	2.40	0.00	0.00	0.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	76.73	0.00	0.80	2.78	4.77	1.59	1.99	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	68.66	0.61	0.00	2.43	3.04	4.25	0.61	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.96	0.69	2.08	2.08	0.00	2.08	5.53	0.00	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	87.40	0.38	1.90	4.18	5.32	1.14	2.66	0.00	2.66	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	75.40	0.00	0.52	2.07	5.16	1.03	0.52	0.00	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.60	0.00	1.81	1.21	6.65	1.81	7.86	0.00	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	78.59	0.32	0.63	4.44	2.54	2.54	1.27	0.00	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	100.75	0.00	0.53	4.26	5.33	2.13	0.53	0.00	2.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	48.27	0.00	0.00	3.45	3.45	2.30	7.47	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	97.19	1.03	0.00	3.60	7.71	1.54	2.06	0.00	3.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	77.81	0.00	0.71	2.12	9.90	2.83	0.71	0.00	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	57.88	0.57	1.13	2.84	2.27	1.13	10.78	0.00	1.70	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	89.45	0.42	0.42	4.99	4.16	2.91	1.66	0.00	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	0.00	0.00	1.57	7.05	2.35	0.78	0.00	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	38.83	0.42	0.42	4.59	5.01	1.25	11.69	0.00	2.09	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	84.10	0.00	0.00	6.50	4.65	0.93	1.86	0.00	2.32	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	66.24	0.00	0.00	6.02	3.35	1.34	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.98	0.00	1.07	2.67	3.74	0.00	14.97	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	72.33	0.00	0.40	4.45	7.68	0.00	2.02	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	0.00	0.00	0.00	5.51	0.92	0.00	0.00	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	34.68	0.00	0.00	4.45	3.56	0.00	8.00	0.00	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	71.23	0.00	0.00	3.42	7.41	0.57	1.71	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	59.05	0.00	0.77	2.30	8.44	0.77	1.53	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	0.55	0.00	3.83	7.66	0.55	7.11	0.00	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	77.51	0.00	0.45	1.34	5.35	0.00	2.23	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	62.39	0.26	0.52	1.82	5.46	0.26	1.04	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	0.66	0.66	1.33	4.64	0.66	11.27	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	87.30	2.08	2.08	6.24	4.16	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.96	5.01	0.68	0.91	1.60	0.23	1.14	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	21.84	9.54	2.02	0.92	0.37	0.55	0.18	0.00	0.00	0.55
Macrophage - monocyte derived, donor3	11389-118C3	27.66	9.70	1.05	1.18	1.97	0.52	0.79	0.13	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	15.93	0.53	0.53	0.53	0.00	0.00	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	22.98	58.94	2.69	0.32	0.32	3.49	0.00	1.43	0.95	1.11
Mallassez-derived cells, donor3	11930-125I4	24.74	31.83	2.36	1.11	0.42	1.25	0.14	0.83	0.56	1.11
Mammary Epithelial Cell, donor1	11273-116H4	41.25	3.69	1.40	3.19	3.19	2.29	0.10	0.00	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	32.43	3.47	1.45	2.90	2.90	1.16	0.00	0.00	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	54.13	1.25	0.25	0.50	3.49	0.50	0.00	0.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	722.00	391.17	16.95	10.85	3.39	29.83	11.52	25.76	49.49	26.44
Mast cell, donor1	11563-120D6	148.59	128.15	2.70	4.87	6.16	2.27	2.05	22.17	4.65	15.68
Mast cell, donor2	11565-120D8	17.24	40.42	0.30	0.59	8.32	0.00	0.89	1.19	0.00	2.97
Mast cell, donor3	11566-120D9	13.28	53.58	0.00	0.23	7.20	0.00	0.68	1.13	0.45	2.25
Mast cell, donor4	11567-120E1	17.37	47.69	0.00	0.35	11.35	0.00	0.53	1.95	0.00	2.66
Mast cell, expanded and stimulated, donor5	11940-126A5	123.42	234.32	2.00	1.89	5.10	2.22	2.00	18.63	3.77	20.52
Mast cell, expanded and stimulated, donor8	11942-126A7	91.05	77.63	4.67	3.50	5.25	4.67	2.92	4.67	4.67	32.10
Mast cell, expanded, donor5	11939-126A4	101.18	96.37	0.57	1.49	6.42	1.26	1.72	6.77	0.46	11.36
Mast cell, expanded, donor8	11941-126A6	191.97	85.19	2.85	5.69	6.36	2.68	4.52	17.41	3.35	20.25
Melanocyte - dark, donor1	11502-119F8	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	12.81	0.69	0.35	0.35	2.77	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	11.08	0.07	0.65	0.87	1.30	0.29	0.14	0.00	0.14	0.00
Melanocyte - light, donor1	11274-116H5	7.99	0.00	0.00	1.18	1.41	0.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	12.28	0.00	0.00	0.00	1.36	0.00	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	10.41	0.00	0.00	1.73	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.51	0.10	0.42	0.73	1.46	0.21	0.00	0.00	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	6.99	0.00	0.00	1.34	1.34	0.00	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	26.25	0.00	0.27	3.48	1.34	0.00	0.54	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	17.49	0.62	0.50	4.34	0.37	0.50	3.97	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	12.32	0.00	0.00	5.72	0.00	0.88	3.08	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	17.77	0.16	0.49	2.61	0.90	0.90	0.16	0.00	0.24	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.41	1.14	0.86	5.13	0.86	1.71	0.00	0.00	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	65.81	30.29	4.73	4.73	1.21	3.72	0.91	0.91	3.42	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26.28	3.94	0.00	2.63	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	0.00	1.31	1.31	2.62	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	0.00	0.72	0.00	2.87	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	54.00	0.85	0.64	3.39	1.91	0.21	0.21	0.00	1.48	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.66	1.51	1.01	1.51	0.00	0.50	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.79	1.32	0.88	2.42	0.44	0.00	0.00	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.96	1.46	1.46	3.65	1.46	0.00	0.00	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.34	1.02	0.61	3.27	1.64	0.20	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.67	6.37	0.42	2.35	0.14	0.97	2.22	0.00	1.11	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	19.33	0.00	0.00	1.86	2.97	0.00	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.21	0.00	1.97	2.76	0.79	1.32	0.39	0.00	1.45	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	24.93	3.26	0.30	2.37	1.78	0.59	0.30	0.00	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.98	1.92	0.00	2.56	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.41	1.06	2.13	3.54	1.42	1.77	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.45	0.31	0.31	0.31	1.25	1.25	0.31	0.00	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	2.18	0.73	1.45	0.73	0.73	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	32.88	7.69	3.18	2.39	1.33	2.12	0.53	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	27.03	1.00	4.00	1.50	0.00	1.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	43.00	1.01	1.88	2.38	1.08	2.53	0.29	0.22	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	2.70	0.00	0.00	4.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.19	3.69	0.00	1.48	0.74	0.25	0.99	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.72	3.83	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.47	1.86	0.00	2.17	0.31	0.31	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.20	2.49	0.00	0.83	0.21	0.00	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.03	4.00	0.50	1.75	0.25	0.50	2.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.17	1.40	0.93	0.93	0.47	0.93	0.00	0.00	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	18.70	3.05	0.41	1.83	0.41	0.00	1.22	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.88	3.56	0.79	0.00	0.40	0.79	0.79	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	0.88	0.00	0.88	0.88	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	5.32	0.38	0.00	0.38	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	5.26	0.00	2.63	1.32	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.16	1.27	0.85	0.64	0.42	0.42	2.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.97	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	29.21	1.49	0.00	1.49	0.60	0.60	2.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.59	1.25	0.25	2.01	1.00	1.76	3.26	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.98	1.19	0.48	0.24	0.24	0.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	15.48	1.11	0.00	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.02	2.07	1.15	3.68	1.38	0.69	0.69	0.00	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.20	2.52	0.21	0.63	0.63	0.63	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	26.50	3.26	0.41	3.87	0.20	1.43	1.83	0.00	0.61	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	21.02	0.86	1.07	3.00	0.43	1.50	0.86	0.00	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	1.78	0.44	1.56	0.44	0.44	1.11	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.84	1.53	0.44	8.98	0.66	1.31	1.31	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.13	0.00	0.51	1.52	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	4.97	0.00	1.66	4.97	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.55	1.36	1.36	10.06	1.09	0.82	0.54	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.47	2.65	0.00	0.59	0.88	0.29	0.88	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	3.27	0.00	11.99	0.00	0.00	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.47	3.84	1.44	8.65	0.00	0.96	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.01	3.60	0.40	3.20	0.00	1.20	0.80	0.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	50.74	5.48	0.00	4.11	0.00	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.54	3.00	2.50	8.51	0.00	2.50	0.00	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	36.69	2.04	2.04	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	46.86	5.69	1.75	8.76	1.31	2.63	0.44	0.00	1.75	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	1.10	0.00	1.10	4.41	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.34	5.76	0.64	4.48	0.64	0.00	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	55.78	9.17	1.98	6.69	1.49	1.24	0.25	0.00	1.49	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	3.48	0.00	1.39	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	53.04	4.42	0.00	11.05	6.63	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	44.44	3.76	2.05	5.81	1.03	0.68	1.03	0.00	0.68	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	2.19	0.00	1.31	0.00	0.44	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	55.75	4.26	0.36	1.42	2.84	0.71	0.71	0.00	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.29	6.45	1.68	6.73	0.28	0.56	0.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	1.66	0.00	1.25	0.83	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	34.38	4.66	0.00	1.17	0.58	0.00	0.00	1.75	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	49.47	3.32	0.60	2.71	0.30	0.60	0.00	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	2.50	0.42	0.42	0.00	0.42	1.67	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	38.79	6.46	0.00	0.92	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	21.06	2.28	0.00	0.57	0.00	1.71	0.00	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	45.19	3.32	0.69	1.24	1.66	0.28	0.28	0.97	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	35.50	4.15	0.00	1.55	0.78	0.78	0.78	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	1.72	0.00	2.14	0.86	0.86	0.86	0.00	0.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	30.49	5.08	0.00	1.27	0.64	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.57	5.34	0.00	2.40	0.27	0.00	0.80	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.23	4.19	1.20	1.80	1.20	1.20	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	46.19	5.65	0.42	0.71	0.85	0.85	0.42	0.28	0.28	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	35.35	5.10	1.27	3.19	0.32	0.96	0.32	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.57	1.55	0.22	0.66	1.11	0.00	0.66	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	34.13	6.83	0.38	3.41	0.00	0.00	0.38	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	43.18	5.68	1.70	3.98	1.14	0.57	0.85	0.85	0.28	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.38	2.95	0.49	0.49	0.49	0.25	1.72	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	43.01	5.87	0.00	3.91	1.30	0.65	0.65	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.10	6.76	1.76	2.65	1.76	1.47	0.00	0.59	0.59	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.85	6.05	2.31	2.02	0.29	0.58	1.15	0.29	1.73	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	44.10	13.19	3.71	2.89	0.82	2.06	1.65	1.65	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	55.98	5.66	0.89	1.49	2.98	1.19	0.60	0.89	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	3.77	3.77	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.63	1.64	1.31	1.31	0.00	0.66	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	0.00	0.00	1.05	2.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.55	0.79	0.79	2.57	1.98	1.19	0.79	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	24.21	0.00	0.00	1.86	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.28	3.76	0.75	1.88	3.00	0.00	1.13	0.00	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.58	1.07	0.80	0.80	0.53	0.00	1.07	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.91	0.34	1.36	1.81	0.57	1.02	0.00	0.00	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.21	0.74	0.00	1.47	1.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.54	1.83	0.37	2.56	0.37	0.37	0.37	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	1.56	0.00	3.11	1.56	0.00	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.77	0.53	4.28	2.67	1.60	0.53	0.00	0.00	2.14	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	41.41	1.01	0.00	2.02	1.01	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.78	0.84	2.11	3.79	0.42	0.00	0.00	0.00	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	1.36	8.17	0.00	0.00	0.00	0.00	0.00	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	9.54	0.00	2.54	0.00	0.00	0.64	0.00	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	40.78	0.00	1.51	4.53	0.00	0.00	0.00	0.00	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	110.92	3.26	3.26	3.26	0.00	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	100.39	0.00	0.00	12.55	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.34	0.22	0.86	2.15	1.29	0.00	0.22	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.27	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	69.42	4.67	3.34	1.33	2.00	1.33	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	104.34	1.67	0.83	2.92	0.42	1.67	0.42	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.92	21.68	3.04	2.28	1.52	2.28	0.57	0.76	0.19	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	79.79	12.77	3.19	4.79	6.38	7.98	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	66.63	8.16	0.68	2.04	1.36	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	14.70	5.51	1.84	0.00	7.35	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	76.17	5.86	1.67	7.12	2.09	1.26	0.42	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	72.06	4.88	2.09	3.02	0.46	2.32	0.70	0.00	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	62.42	18.38	1.89	2.43	1.89	1.62	0.00	0.27	1.08	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.69	29.22	2.31	2.94	1.26	1.68	1.05	0.84	0.63	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	111.35	0.00	0.00	0.00	11.13	0.00	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.07	8.44	4.96	6.45	0.00	0.50	0.00	0.00	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	56.57	24.09	4.60	2.44	0.00	1.35	0.00	0.81	0.27	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	69.82	11.11	1.81	3.85	1.59	3.63	0.91	0.23	1.59	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	57.97	13.72	2.12	1.31	1.47	1.31	0.33	0.65	0.65	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	38.09	46.84	2.92	1.82	1.09	2.19	1.46	1.09	1.82	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	74.26	19.10	2.65	1.06	1.06	3.71	1.59	1.06	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	111.66	5.40	3.00	3.00	1.80	4.80	0.60	0.00	1.80	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	37.08	65.96	11.49	3.28	0.98	5.25	0.33	0.98	2.30	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	70.74	10.90	1.79	2.28	1.30	1.63	0.49	0.33	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	44.98	58.21	5.12	2.82	1.23	2.65	1.23	1.76	0.71	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	85.79	28.13	2.81	2.11	0.00	1.41	0.00	1.41	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	116.77	13.33	0.92	2.30	1.84	0.92	0.92	0.00	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	90.30	19.60	2.57	1.61	0.64	1.29	0.96	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	50.70	57.60	6.21	2.41	0.34	4.83	0.69	1.72	2.07	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	103.67	40.46	0.00	2.53	22.76	0.00	7.59	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.90	54.36	2.01	2.90	0.89	1.56	0.45	0.45	0.22	1.78
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	83.41	20.75	0.85	2.96	0.85	0.85	0.42	1.27	0.42	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	78.80	21.60	3.32	2.61	1.19	1.42	0.24	0.71	0.95	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	91.86	24.47	0.43	1.29	0.86	1.29	1.29	0.43	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	117.36	45.14	0.00	0.00	27.08	9.03	9.03	36.11	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	83.64	19.33	1.33	2.00	0.00	1.00	0.00	1.00	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.48	28.86	0.45	3.61	0.45	0.90	2.25	1.80	1.35	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	15.87	0.40	3.17	0.00	0.00	0.79	0.40	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	104.01	26.00	2.79	0.93	0.00	2.79	1.86	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	101.78	30.65	1.89	1.14	1.14	1.14	1.14	1.89	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	63.22	17.27	0.98	1.96	0.33	0.98	0.33	0.00	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	122.02	18.74	0.87	3.05	0.87	0.87	0.87	0.00	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	66.94	45.23	2.71	2.71	1.36	0.00	2.26	2.71	1.81	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	75.84	22.05	0.00	2.65	0.88	0.00	0.00	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	124.99	28.59	0.00	0.66	0.00	1.99	1.33	0.66	1.99	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	105.16	40.18	0.50	1.98	0.50	1.49	1.49	0.50	0.50	2.48
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	92.64	19.14	0.77	1.53	1.15	0.77	0.77	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	114.32	64.12	2.12	3.02	0.30	1.21	0.60	0.60	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.29	56.58	0.66	1.99	1.33	0.88	1.55	1.99	1.11	1.99
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	73.86	24.40	1.36	1.36	0.68	1.36	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	132.85	10.22	0.00	0.00	0.00	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	135.96	30.48	0.00	1.83	0.61	0.61	1.83	0.00	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	124.01	15.74	0.31	1.26	1.89	0.94	0.31	0.00	0.63	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	123.79	26.03	0.61	2.72	1.51	2.72	1.82	0.61	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	97.31	22.94	0.00	0.00	0.00	2.37	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	88.42	3.40	0.00	0.00	0.00	0.00	4.53	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	141.62	15.17	5.06	0.00	5.06	0.00	10.12	10.12	10.12
Myoblast, donor1	11241-116D8	22.36	15.40	2.86	3.11	0.99	2.73	0.37	0.25	0.75	0.00
Myoblast, donor2	11322-117D8	27.43	18.80	1.92	2.69	2.30	1.15	0.96	1.73	0.96	0.38
Myoblast, donor3	11398-118D3	30.10	30.10	3.70	4.54	2.19	2.86	0.50	2.69	0.67	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	36.63	16.64	1.02	1.61	2.33	0.58	0.00	2.63	1.90	1.61
Natural Killer Cells, donor1	11230-116C6	24.91	46.13	4.31	0.92	1.54	3.08	0.62	29.21	2.15	15.38
Natural Killer Cells, donor2	11311-117C6	22.01	30.76	0.90	1.21	3.02	0.00	1.21	20.81	1.21	7.54
Natural Killer Cells, donor3	11387-118C1	30.00	33.13	2.21	1.10	4.42	0.74	0.00	23.56	2.02	8.65
Neural stem cells, donor1	11275-116H6	25.04	0.73	0.36	2.90	0.36	1.81	0.00	0.00	1.45	0.00
Neural stem cells, donor2	11352-117H2	13.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	17.07	0.00	1.14	2.28	1.14	0.00	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	7.27	0.44	0.22	0.44	0.44	0.22	0.00	0.00	0.00	0.00
Neurons, donor3	11655-122E8	14.80	0.82	1.64	1.64	0.00	1.64	0.00	0.00	1.64	0.82
Neutrophils, donor1	11233-116C9	15.78	60.32	0.00	0.00	0.00	0.00	1.86	4.64	0.93	8.35
Neutrophils, donor2	11314-117C9	14.49	23.19	0.00	0.00	0.00	0.00	0.00	11.60	0.00	11.60
Neutrophils, donor3	11390-118C4	33.60	97.73	3.05	0.61	0.61	0.00	1.83	15.27	0.61	21.99
Nucleus Pulposus Cell, donor1	11252-116F1	38.95	4.99	1.19	1.78	1.90	1.07	0.47	0.00	0.83	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	9.44	5.21	0.00	2.28	0.33	0.65	0.33	0.00	1.63	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.82	0.60	0.60	1.60	0.40	0.60	1.60	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	33.45	1.65	0.41	2.89	1.51	0.83	0.55	0.00	0.96	0.28
Olfactory epithelial cells, donor2	11934-125I8	30.69	0.43	1.30	4.05	1.30	1.16	0.14	0.00	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	25.99	0.34	0.45	1.70	2.38	0.34	0.00	0.00	0.68	0.00
Olfactory epithelial cells, donor4	11936-126A1	45.87	5.45	1.07	2.53	2.73	1.07	0.68	0.00	0.29	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	39.72	0.60	3.01	1.20	1.20	2.41	0.00	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.85	7.23	0.21	0.85	0.64	0.43	0.00	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	5.72	5.72	0.00	0.00	0.00	0.00	0.00	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	1.24	0.62	1.24	2.48	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	13.68	1.17	0.39	2.54	0.98	0.39	0.20	0.00	0.39	0.00
Osteoblast, donor2	11354-117H4	21.77	7.02	2.11	2.11	1.40	2.11	0.00	0.70	0.70	0.70
Osteoblast, donor3	11426-118G4	39.63	3.55	1.78	5.15	1.24	1.07	0.36	0.18	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	47.85	3.87	3.71	5.05	3.62	2.36	0.25	0.00	1.01	0.17
Pericytes, donor1	11491-119E6	5.56	0.11	0.00	2.56	0.22	0.22	1.45	0.00	0.33	0.00
Pericytes, donor2	11571-120E5	6.11	13.58	0.00	1.13	0.45	0.00	0.91	0.68	0.00	0.00
Pericytes, donor3	11652-122E5	25.63	1.22	2.03	1.83	0.20	1.42	0.41	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	15.71	0.45	0.45	2.49	0.90	0.57	0.11	0.00	0.34	0.00
Perineurial Cells, donor2	11579-120F4	12.42	0.00	0.28	1.10	0.64	0.83	0.37	0.00	0.46	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.22	86.38	11.79	1.59	3.19	5.42	3.51	10.84	1.91	12.75
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	54.11	52.89	5.39	0.98	2.69	2.45	1.47	3.43	0.98	2.94
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	51.64	55.13	3.75	1.29	3.75	1.81	0.78	12.55	1.16	6.08
Placental Epithelial Cells, donor1	11278-116H9	26.31	0.00	0.96	1.91	2.87	0.48	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	16.63	0.00	1.11	1.11	3.33	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	34.95	0.00	0.39	2.36	2.55	0.39	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	45.25	0.00	0.32	0.32	2.22	0.95	0.32	0.00	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	40.52	0.38	2.06	2.44	2.06	1.31	0.75	0.19	0.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	80.14	2.74	5.61	6.92	3.00	5.22	0.91	0.13	1.96	0.26
Preadipocyte - breast, donor2	11328-117E5	53.36	0.45	1.13	1.58	2.70	0.90	2.03	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	50.62	0.21	2.34	2.34	2.88	1.70	1.07	0.00	1.39	0.00
Preadipocyte - omental, donor2	11329-117E6	68.09	2.62	2.62	6.11	0.87	3.93	1.75	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	61.45	0.29	1.43	2.58	2.01	1.86	0.00	0.14	1.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	9.84	0.00	1.97	0.98	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	60.20	1.54	3.38	6.14	3.99	2.15	1.23	0.00	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	60.38	1.24	2.66	4.25	3.54	1.77	0.89	0.00	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	42.23	0.68	2.55	4.43	3.07	3.58	0.17	0.00	1.19	0.00
Preadipocyte - visceral, donor1	11280-116I2	37.35	1.12	5.87	4.56	3.54	5.03	0.75	0.09	0.93	0.19
Preadipocyte - visceral, donor2	11357-117H7	21.17	0.92	3.22	2.76	5.06	1.38	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	25.60	0.21	1.88	3.45	1.78	2.40	3.34	0.00	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.30	0.00	0.00	0.45	1.66	0.00	0.00	0.00	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	44.55	7.04	3.11	3.79	1.49	3.93	1.90	0.00	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	28.97	0.06	0.98	0.55	2.02	1.04	0.06	0.00	0.49	0.00
Prostate Stromal Cells, donor1	11254-116F3	28.02	0.34	1.59	1.71	1.03	0.91	0.34	0.00	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	31.92	0.54	1.08	4.30	1.97	1.08	0.54	0.00	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	20.75	1.15	0.63	1.77	1.98	1.77	0.21	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.74	1.46	0.00	0.73	2.55	1.46	0.00	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.97	1.04	3.33	2.15	1.25	2.29	0.14	0.00	0.69	0.00
Renal Epithelial Cells, donor1	11517-119H5	24.35	2.54	1.01	3.55	1.01	1.01	0.00	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	26.32	2.13	0.00	1.42	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	25.09	0.53	3.60	3.28	1.59	2.86	0.32	0.00	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	0.00	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.93	0.13	0.00	0.54	0.40	0.00	0.54	0.00	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	10.66	0.00	0.00	1.55	1.33	0.22	0.22	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.00	0.00	1.33	0.67	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	13.65	0.66	1.54	6.60	1.54	0.44	0.00	0.00	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	21.94	2.51	0.00	3.13	0.63	1.88	0.00	0.00	0.63	0.63
Renal Mesangial Cells, donor3	11679-122H5	12.21	0.83	0.00	3.33	0.83	0.55	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.64	1.07	0.00	1.88	3.22	1.61	0.27	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	0.84	0.42	0.42	2.11	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.02	3.66	0.58	2.70	1.16	0.19	0.19	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.22	2.85	0.52	1.04	1.04	1.04	0.00	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.90	3.41	0.28	1.99	0.85	0.85	0.00	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	4.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.55	1.25	0.75	1.51	1.51	0.25	0.50	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	29.40	1.60	0.94	3.21	1.34	1.20	0.27	0.27	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	4.47	0.89	0.00	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1.10	3.30	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	2.32	2.90	0.00	1.16	1.16	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.80	0.39	0.00	0.39	0.39	0.00	1.56	0.52	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	9.33	0.20	0.00	0.79	0.79	0.00	0.30	0.00	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.69	0.56	0.00	0.67	0.22	0.00	0.22	0.22	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.58	0.74	0.37	0.87	0.00	0.00	3.72	0.00	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.62	0.82	0.00	0.35	0.47	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	10.40	0.00	0.00	0.69	0.46	0.00	0.23	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.63	0.41	0.00	0.55	0.14	0.00	1.23	0.00	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.83	0.15	0.00	0.45	0.76	0.30	0.00	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	4.84	0.90	0.00	0.72	0.00	0.00	0.00	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.61	0.43	0.00	0.43	0.57	0.14	1.72	0.29	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.87	0.43	0.11	0.43	0.21	0.11	0.11	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.19	0.66	0.00	0.22	0.66	0.22	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.28	0.19	0.00	0.19	0.38	0.19	0.96	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	11.65	0.28	0.09	1.02	0.93	0.19	0.09	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	11.84	0.38	0.00	0.75	0.19	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	8.23	0.00	0.00	1.19	0.27	0.13	1.73	0.13	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.17	0.78	0.29	0.78	0.97	0.00	0.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	9.55	0.38	0.00	0.19	0.76	0.19	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.97	0.32	0.00	1.17	0.32	0.21	2.14	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	13.73	0.28	0.00	1.40	0.28	0.56	0.28	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	9.74	0.68	0.17	0.17	0.51	0.00	0.00	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.94	0.18	0.00	0.73	0.91	0.18	2.19	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.28	0.49	0.00	0.25	0.12	0.00	0.49	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	10.88	0.13	0.00	0.81	0.54	0.13	0.13	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	5.66	0.00	0.24	0.71	0.47	0.24	2.59	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.50	0.79	0.00	0.99	0.60	0.20	0.00	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.16	0.00	0.00	0.47	0.70	0.00	0.47	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.54	0.21	0.00	1.87	0.62	0.00	2.49	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	9.51	0.00	0.00	0.88	0.44	0.22	0.22	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	14.62	0.21	0.00	0.42	0.63	0.00	0.42	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.31	0.67	0.00	2.15	1.35	0.00	2.42	0.13	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	12.26	0.17	0.00	1.02	0.51	0.00	0.00	0.34	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	16.00	0.19	0.00	0.39	0.58	0.00	0.19	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	9.28	0.17	0.00	1.72	0.00	0.34	1.72	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	10.56	0.00	0.00	0.69	0.96	0.00	0.14	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	8.37	0.16	0.33	0.82	0.49	0.16	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	8.18	0.51	0.17	2.39	0.00	0.34	0.68	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	11.39	0.59	0.00	0.44	0.74	0.15	0.00	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.13	0.00	0.00	0.00	1.07	0.00	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	3.04	0.28	0.00	0.55	0.14	0.00	1.38	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	3.10	0.00	0.00	0.48	0.24	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	3.63	0.40	0.00	0.20	0.40	0.00	0.40	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	0.85	0.28	0.00	0.19	0.00	0.00	0.38	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	2.79	0.00	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	2.12	0.30	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	1.59	1.22	0.00	0.24	0.12	0.00	0.49	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	8.15	3.78	0.00	0.29	0.73	0.15	0.00	0.73	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	3.04	1.83	0.00	0.00	0.61	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1.81	0.90	0.00	0.30	0.30	0.00	0.30	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	3.85	1.58	0.00	0.45	0.45	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	5.09	4.49	0.00	0.30	1.20	0.00	0.00	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	4.13	1.77	0.00	0.00	0.35	0.00	0.59	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.12	1.28	0.21	0.21	0.21	0.00	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	3.00	3.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	20.69	0.94	0.19	4.70	0.75	0.56	2.63	0.00	0.75	0.00
Schwann Cells, donor2	11578-120F3	17.01	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.35	2.19	0.44	3.94	0.66	0.22	0.44	0.00	0.22	0.22
Sebocyte, donor1	11220-116B5	89.83	1.64	7.67	2.74	6.57	4.38	1.10	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	39.52	7.35	1.38	1.84	5.06	2.76	0.46	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	23.70	2.27	0.62	1.44	2.06	1.65	0.82	0.00	0.62	0.00
Sertoli Cells, donor1	11255-116F4	51.35	0.00	1.66	0.00	3.31	6.63	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	0.00	2.82	0.00	0.00	5.65	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.31	31.23	2.82	4.57	1.41	2.90	0.35	2.55	1.41	0.79
Skeletal Muscle Cells, donor2	11358-117H8	10.84	8.67	0.00	0.72	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	27.59	14.21	0.84	1.67	4.18	4.18	6.69	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.88	5.18	0.00	2.20	1.10	0.63	3.61	0.16	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	19.47	8.77	0.15	1.64	2.08	0.30	3.42	0.15	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	22.47	20.16	1.08	1.39	1.69	1.08	5.08	0.31	0.46	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.53	4.28	1.26	2.77	2.14	1.64	0.50	0.13	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.52	5.56	0.43	2.85	3.00	0.43	0.43	0.00	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.14	23.51	0.89	4.46	2.38	0.89	0.10	0.40	0.69	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	62.77	69.84	2.11	3.37	1.85	3.54	0.59	0.76	4.21	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	21.71	18.09	0.00	2.90	0.72	0.00	0.00	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.01	7.71	0.69	1.51	0.96	0.55	2.75	0.14	0.69	0.28
Skin - palm, donor1	10286-104F7	42.98	2.69	0.00	2.69	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	41.66	0.14	0.29	0.14	0.72	0.72	0.14	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	466.20	6.54	3.27	4.09	4.91	20.45	0.00	0.00	9.00	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	43.36	0.13	0.52	0.39	1.69	1.30	0.13	0.00	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	21.82	0.28	2.64	1.67	1.53	4.73	0.28	0.00	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	46.84	0.28	1.55	2.81	2.67	2.67	0.70	0.14	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	215.89	2.75	13.11	8.67	13.74	18.18	2.96	0.00	5.71	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	37.85	0.00	1.05	1.87	1.65	2.02	0.30	0.00	0.45	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.34	0.62	3.39	4.32	0.31	2.16	3.39	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.12	3.33	13.12	8.00	0.67	10.67	9.12	0.00	0.89	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	34.09	0.00	4.11	6.47	3.53	4.70	0.00	0.00	1.76	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.14	3.31	0.66	3.09	0.88	1.99	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.14	0.79	1.58	3.15	1.58	0.79	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.86	0.00	3.09	6.18	0.00	6.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	0.00	1.00	3.00	2.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.57	0.00	2.66	2.53	0.93	2.13	0.40	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.51	0.22	1.55	1.11	1.77	0.44	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.37	0.00	1.28	1.54	0.90	0.51	2.05	0.00	0.64	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.77	0.98	0.00	3.26	0.65	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.40	3.54	0.30	2.66	0.89	1.77	0.30	0.00	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.34	5.27	0.14	1.28	1.28	0.14	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.40	1.63	1.14	1.95	2.44	1.30	0.00	0.00	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.31	3.65	0.30	3.04	2.13	0.30	0.00	0.30	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.24	0.51	3.28	1.77	3.54	2.27	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	30.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	13.35	0.00	1.91	1.91	1.43	0.48	0.95	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.76	1.47	0.44	2.21	2.06	0.88	0.59	0.00	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.68	0.43	0.00	2.15	1.08	0.43	0.00	0.00	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.50	0.84	0.31	2.94	1.78	0.42	0.10	0.00	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	18.10	0.31	0.62	3.71	1.86	0.46	0.15	0.00	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	0.00	1.08	2.16	0.00	0.00	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.24	0.60	0.60	1.79	0.60	1.20	4.18	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	20.14	0.34	0.00	2.39	2.05	0.68	0.34	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	18.14	1.33	0.47	4.48	1.10	0.16	0.08	0.00	0.55	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	34.22	1.51	5.54	5.33	2.31	4.43	0.50	0.20	1.01	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	31.63	2.05	1.37	2.50	1.37	1.59	0.68	0.00	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	26.57	0.00	1.81	2.42	0.60	2.42	0.60	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.46	0.00	1.32	1.06	2.38	0.00	0.00	0.00	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	12.78	0.00	1.86	2.40	0.27	0.53	3.60	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.44	0.00	1.38	3.63	2.63	1.50	0.63	0.00	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	42.36	0.51	2.54	2.54	0.76	3.04	0.76	0.00	1.52	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.07	0.30	1.06	3.47	3.02	1.36	0.30	0.00	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	0.00	1.50	1.50	0.75	0.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	391.54	19.38	0.00	3.88	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	29.30	0.00	6.51	5.12	3.72	2.79	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.64	0.00	0.50	1.51	1.01	2.02	0.50	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.36	0.31	0.94	4.39	0.00	1.88	2.19	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.09	0.29	0.59	2.65	0.59	0.88	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	14.25	0.92	1.08	5.00	2.33	0.92	0.25	0.00	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.10	0.93	0.47	1.87	1.40	0.00	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	14.10	0.29	1.30	1.58	0.72	0.43	0.14	0.00	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.46	1.53	0.76	2.04	1.78	0.76	0.00	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.55	0.00	1.13	1.69	1.32	0.94	1.88	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.08	0.70	1.40	2.52	1.12	1.26	0.14	0.00	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	16.42	1.42	1.01	0.92	1.51	0.50	0.17	0.00	0.34	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.19	0.00	0.48	2.38	1.90	1.43	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.28	0.00	0.98	0.98	0.00	0.98	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.60	0.44	3.31	6.85	0.88	3.09	6.63	0.00	2.21	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	18.14	0.00	4.97	4.68	2.34	1.46	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	77.94	2.92	0.78	3.50	2.14	1.55	0.19	0.00	1.36	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	50.51	7.14	2.91	8.73	1.06	5.02	0.79	0.26	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	26.41	2.98	8.18	2.98	0.37	3.35	0.74	0.00	2.98	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	0.36	1.08	5.03	2.16	2.87	0.00	0.00	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.69	1.99	1.14	5.11	0.85	2.27	0.00	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	33.87	3.15	3.15	3.54	0.39	3.54	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	46.47	0.51	2.54	3.30	2.03	3.05	0.25	0.00	2.03	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	71.48	0.80	2.80	2.80	0.80	3.59	0.00	0.00	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	61.03	0.00	0.84	0.42	0.84	2.09	0.42	0.00	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	48.13	0.46	0.92	2.75	1.83	0.92	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	78.94	1.85	6.40	4.38	1.68	9.59	0.67	0.00	3.20	0.34
Synoviocyte, donor2	11368-117I9	39.56	1.01	0.84	1.17	1.68	0.84	0.34	0.00	0.50	0.17
Synoviocyte, donor3	11440-118H9	46.69	2.90	0.45	0.89	2.01	1.56	4.92	0.00	1.12	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	25.73	1.07	0.71	1.79	1.79	0.00	0.71	0.00	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	0.00	0.00	0.00	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.08	1.16	0.00	3.70	2.08	0.23	0.23	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	23.30	0.00	1.58	2.01	1.43	1.51	0.36	0.00	0.50	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	24.35	0.39	0.77	0.77	1.16	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	20.04	0.00	0.57	2.29	2.29	0.00	1.72	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	26.45	3.20	0.98	2.83	1.85	1.11	0.62	0.49	0.37	0.25
Urethra, donor2	10319-105A4	61.15	1.80	0.00	5.40	3.60	3.60	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	18.86	0.27	2.66	2.13	1.59	2.66	0.00	0.00	0.80	0.27
Urothelial Cells, donor2	11600-120H7	11.22	0.00	2.00	1.60	1.20	1.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.48	0.00	0.23	1.38	0.23	0.92	0.23	0.00	0.69	0.00
Urothelial cells, donor0	11216-116B1	16.94	0.22	5.80	4.01	1.56	4.24	0.00	0.00	1.11	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	32.03	0.00	0.89	0.89	0.00	4.45	9.79	0.00	7.12
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	40.03	1.43	2.86	1.43	1.43	5.72	11.44	1.43	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	51.34	0.00	0.00	2.05	0.00	0.00	4.79	0.00	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	20.66	61.64	0.34	1.72	1.03	0.34	0.34	6.54	0.00	6.89
Whole blood (ribopure), donor090325, donation2	12177-128I8	16.27	52.29	0.00	1.16	2.91	0.00	0.00	4.65	0.00	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	28.11	0.00	1.04	2.08	0.00	7.29	2.08	0.00	7.29
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	33.96	0.00	1.84	2.75	0.00	3.67	8.26	0.00	10.10
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	28.30	0.00	0.00	0.00	0.91	0.00	5.48	0.91	2.74
Wilms' tumor cell line:G-401	10809-111A8	2.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	50.56	15.92	0.28	0.28	0.84	0.84	0.56	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	134.32	39.26	26.86	6.20	4.13	6.20	2.07	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	2.80	38.50	0.00	0.00	0.76	0.00	0.00	1.27	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	104.01	43.88	0.00	4.41	1.86	0.23	0.70	0.00	0.23	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	37.39	115.62	0.47	0.47	0.95	0.12	0.47	0.83	0.59	3.80
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	142.04	86.53	1.36	11.43	6.80	1.09	1.63	6.53	1.90	5.71
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	124.52	38.79	0.56	2.25	3.37	0.28	1.12	4.50	0.84	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	83.75	42.30	0.42	1.69	2.96	1.06	1.90	4.02	0.00	3.60
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	83.84	30.76	0.54	0.00	2.18	0.82	1.09	4.63	0.54	3.81
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	270.11	64.77	0.88	7.49	4.41	0.88	3.08	1.32	2.20	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	301.78	110.26	1.23	4.90	8.98	2.86	0.82	1.23	1.63	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	438.00	45.43	1.94	7.38	5.44	2.72	2.33	0.78	2.72	2.33
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	64.40	13.25	0.37	0.55	2.02	0.37	0.55	0.55	0.55	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	409.55	85.81	0.00	0.00	3.90	0.00	19.50	19.50	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	68.55	19.52	0.00	0.70	3.02	0.00	0.70	0.23	0.00	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	210.23	18.38	5.70	6.21	2.85	4.14	1.29	0.26	2.85	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	130.93	24.84	3.51	4.38	4.97	0.58	1.46	1.46	0.58	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.84	29.28	0.46	1.86	2.79	0.46	0.46	0.93	0.00	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	165.32	23.85	1.23	3.70	4.52	1.65	1.65	2.88	0.41	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	178.95	4.30	0.31	1.23	3.07	0.00	0.61	0.61	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	115.64	29.87	1.28	1.71	2.99	0.00	0.43	3.41	0.43	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	87.35	26.08	1.52	1.21	3.64	0.00	0.91	1.52	0.30	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	116.26	31.29	1.44	3.37	4.33	1.20	0.72	1.93	0.24	3.13
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	43.66	26.06	0.00	2.00	1.78	0.45	0.22	0.22	0.00	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	146.43	43.69	0.67	1.67	5.00	2.00	1.00	0.67	1.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	53.89	20.44	0.00	1.86	9.29	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	74.20	96.43	0.00	0.75	3.77	0.75	1.13	2.26	0.75	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	465.35	101.62	2.18	14.83	6.98	3.49	5.67	30.09	3.93	4.80
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	104.97	74.98	0.00	1.87	16.87	0.00	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	31.09	0.00	0.24	0.47	7.06	0.00	0.00	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	30.25	5.43	0.78	1.09	2.64	0.62	0.16	0.00	0.62	0.31
adipose, donor1	10184-103D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	1.22	1.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	22.33	19.88	0.00	0.00	0.00	0.00	0.27	0.00	0.00	1.09
adipose, donor4	10187-103D7	56.34	39.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	7.28	3.64	0.00	0.00	0.00	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	31.35	10.41	0.40	0.93	3.34	0.00	0.27	0.27	1.07	2.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.24	1.07	0.00	0.71	5.36	0.71	0.36	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	55.41	0.23	0.70	1.62	4.64	0.23	0.70	0.00	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	23.67	5.41	1.35	0.34	0.34	0.34	0.68	0.34	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	26.51	0.00	0.00	1.77	6.19	0.00	13.26	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	20.16	2.37	0.00	0.00	0.00	0.00	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	20.48	7.50	0.41	0.41	0.61	0.00	0.61	0.20	0.20	0.41
amygdala, newborn, donor10223	10360-105E9	12.27	3.87	0.65	1.29	0.97	0.32	0.00	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	46.98	7.00	2.67	4.20	1.15	1.53	0.38	0.00	0.89	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	95.53	8.38	5.07	13.24	2.87	2.87	0.66	1.54	1.54	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	13.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	48.05	3.33	0.59	4.90	1.96	0.98	0.78	0.39	0.59	0.00
appendix, adult	10189-103D9	20.18	31.83	0.00	1.94	1.55	0.00	0.00	2.33	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	12.23	4.08	0.00	1.36	0.00	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	69.10	33.03	4.20	4.06	1.30	3.62	0.43	0.87	2.03	0.58
b cell line:RPMI1788	10427-106D4	8.33	1.34	0.59	1.78	0.74	0.45	0.00	0.15	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	37.46	2.77	11.65	5.27	1.94	2.50	0.28	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	67.78	62.91	1.79	2.58	1.39	1.09	0.40	2.08	1.09	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	48.04	0.00	0.33	0.50	3.51	0.00	0.67	0.00	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	149.88	10.07	1.12	6.15	4.47	0.00	1.68	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	25.97	3.59	1.74	3.15	1.20	1.41	0.11	0.11	0.54	0.11
blood, adult, pool1	10053-101G8	15.50	24.36	0.00	2.21	2.21	0.00	0.00	4.43	0.00	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	26.55	11.99	3.43	4.28	1.71	0.00	0.86	0.00	0.86	0.00
bone marrow, adult	10192-103E3	35.77	18.22	0.67	4.05	2.02	1.35	1.35	2.02	1.35	0.67
brain, adult, donor1	10084-102B3	6.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	10.36	2.12	0.00	0.22	0.11	0.33	0.00	0.11	0.00	0.11
brain, fetal, pool1	10085-102B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	84.90	0.00	0.33	5.62	4.96	1.65	2.31	0.00	1.98	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	83.01	0.00	0.50	2.62	3.25	0.62	0.50	0.00	1.00	0.00
breast, adult, donor1	10080-102A8	155.95	1.89	0.00	4.42	1.89	2.53	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	39.64	0.25	0.25	1.02	4.70	0.38	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	143.17	12.37	1.24	2.78	3.71	1.55	0.31	0.62	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	29.01	1.38	0.00	0.23	0.69	0.23	0.23	0.46	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.53	0.24	0.00	0.48	1.69	0.00	0.24	0.00	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	80.29	0.00	0.66	2.84	5.03	0.98	0.22	0.00	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	2.93	0.27	0.00	0.53	0.27	0.00	0.00	0.00	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	26.48	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	13.72	5.19	0.17	0.00	0.50	0.00	0.33	0.17	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	3.82	0.76	0.00	0.76	0.00	0.00	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	12.45	2.20	0.37	0.00	0.37	0.00	0.37	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	14.57	5.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	5.76	2.14	0.00	0.43	0.21	0.00	0.21	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	2.76	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	3.32	0.00	0.00	0.00	0.00	0.00	1.66	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	5.55	1.01	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	25.58	2.19	1.46	2.19	2.92	1.46	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.06	0.00	0.14	1.73	1.58	0.14	0.00	0.00	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	60.16	0.00	0.99	1.99	1.82	1.66	0.33	0.00	0.83	0.00
cervix, adult, pool1	10013-101C4	17.74	3.67	0.31	3.15	2.10	0.73	0.21	0.21	0.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	40.69	6.55	5.99	7.52	0.98	1.67	0.28	1.11	1.11	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	45.72	1.31	0.00	1.31	1.31	1.31	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	79.04	0.00	2.98	4.85	1.86	1.62	0.75	0.00	1.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	14.91	0.12	0.00	1.23	0.99	0.12	0.12	0.00	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	114.56	0.00	0.00	2.61	3.56	0.47	2.37	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	55.27	0.00	3.42	0.57	3.99	3.13	1.71	0.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	34.10	0.50	1.69	3.08	3.68	0.40	0.80	0.00	0.70	0.00
chorionic membrane cells, donor3	12240-129G8	28.57	1.65	7.69	2.75	2.75	4.40	13.74	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	116.13	52.51	1.01	8.08	2.02	4.04	1.01	8.08	5.05	7.07
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	146.57	44.37	1.73	1.73	1.34	0.58	1.15	2.50	1.54	3.27
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	135.37	49.42	0.21	0.63	10.77	0.63	0.21	0.84	0.84	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	39.80	3.85	0.00	0.26	6.16	0.26	0.26	0.00	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.60	4.35	0.00	0.24	9.68	0.24	0.48	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	51.11	8.35	0.61	0.20	4.48	0.20	0.41	0.00	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	33.27	11.19	0.00	0.88	7.36	0.29	0.29	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	129.53	129.27	1.04	0.78	10.16	0.52	0.52	0.26	0.52	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.26	1.83	0.00	0.69	0.46	0.00	0.00	0.00	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	48.06	0.00	0.17	1.04	1.74	0.35	0.17	0.00	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	4.58	0.00	0.00	0.18	0.73	0.00	0.00	0.00	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	11.02	0.38	0.00	4.18	4.56	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	34.51	4.76	1.19	1.19	3.57	1.19	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	14.69	2.59	0.00	2.23	2.47	0.00	0.12	0.35	0.00	0.00
colon, fetal, donor1	10070-101I7	22.25	4.94	0.00	3.09	1.85	0.00	1.24	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	453.77	265.84	0.00	4.58	27.50	4.58	4.58	9.17	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	50.07	50.07	0.00	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	72.66	11.47	1.27	11.47	2.12	2.55	2.12	0.00	3.40	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.28	10.41	0.91	5.74	4.23	2.87	3.02	0.00	3.02	1.21
cord blood derived cell line:COBL-a untreated	10449-106F8	34.12	9.73	1.69	4.09	2.26	4.37	2.68	0.14	3.95	0.71
corpus callosum, adult, pool1	10042-101F6	13.27	7.30	0.33	1.00	1.00	0.22	0.33	0.22	0.22	0.00
cruciate ligament, donor2	10295-104G7	79.43	8.92	8.10	5.67	4.05	4.05	1.62	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	17.66	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	2.64	1.68	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.25	14.47	0.00	0.00	1.84	0.69	0.23	1.38	0.23	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	48.63	26.24	1.20	0.96	1.93	0.72	0.24	0.96	0.00	0.72
ductus deferens, adult	10196-103E7	13.46	1.99	0.00	0.50	2.99	0.00	0.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	8.64	0.00	1.44	7.20	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.75	5.89	0.00	0.00	2.21	1.47	0.00	0.00	0.00	1.47
dura mater, adult, donor1	10041-101F5	81.60	9.17	2.23	2.64	3.88	1.49	3.22	0.99	1.49	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.98	0.22	0.67	1.55	1.55	0.89	0.89	0.00	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.49	0.72	0.43	3.01	1.58	0.00	0.29	0.00	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	67.83	0.00	1.23	0.62	1.85	1.23	0.00	0.00	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.62	0.00	0.61	0.30	1.21	0.61	0.30	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	70.39	0.62	1.54	0.62	1.54	0.62	0.31	0.31	1.54	0.00
embryonic pancreas cell line:2C6	10603-108E9	66.99	0.00	1.31	1.31	9.19	0.00	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	60.67	4.36	0.00	1.34	1.68	0.00	1.01	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	37.70	10.33	0.18	1.81	2.17	0.72	0.36	0.00	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.44	0.00	0.16	0.16	1.29	0.00	0.00	0.00	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	35.68	22.68	0.22	1.56	2.00	1.11	0.67	0.44	0.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	54.77	25.52	1.21	1.76	1.87	1.76	0.11	0.88	0.77	0.66
epididymis, adult	10197-103E8	21.35	5.23	0.21	2.51	1.26	0.63	0.42	0.42	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.00	0.00	0.53	7.27	2.13	0.71	0.18	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	0.39	0.00	0.00	0.00	0.39	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.27	0.00	0.26	0.66	2.10	0.00	0.26	0.00	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.68	0.00	0.20	1.57	2.85	0.20	0.30	0.00	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	9.86	0.00	0.00	0.45	3.25	0.22	0.45	0.00	0.00	0.00
esophagus, adult, pool1	10015-101C6	12.64	2.23	0.53	0.53	2.34	0.32	0.21	0.11	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.00	0.00	0.00	0.13	3.13	0.13	0.13	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	14.49	4.83	0.00	2.41	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	4.21	4.21	4.21	4.21	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	9.17	1.15	0.00	2.29	0.00	2.29	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	10.20	4.37	0.00	0.00	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	14.49	1.27	0.51	0.25	0.51	0.00	0.00	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	48.85	7.44	0.77	0.51	1.15	0.77	0.13	0.26	0.51	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	38.46	4.51	2.85	1.19	0.95	0.71	0.24	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	3.66	1.88	0.00	0.56	0.38	0.00	0.09	0.00	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	62.45	9.91	0.00	1.20	1.20	1.80	0.30	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	45.35	5.67	5.21	0.91	2.38	1.74	0.18	0.46	1.01	0.46
gall bladder, adult	10198-103E9	34.77	4.59	0.48	2.41	4.83	0.24	0.72	0.48	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	5.91	19.33	0.00	0.00	4.83	0.54	0.00	20.40	0.54	14.50
gamma delta positive T cells, donor2	11938-126A3	6.72	11.20	0.00	0.00	2.61	0.00	0.00	15.69	0.00	10.08
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.05	13.52	0.42	2.75	1.90	0.63	0.42	1.06	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	43.13	0.39	0.19	2.71	7.16	0.00	0.00	0.00	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	0.16	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	65.90	20.13	0.00	1.83	3.66	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	19.19	0.00	0.00	2.28	2.28	0.91	0.23	0.00	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	57.83	0.00	0.57	0.11	2.98	1.15	1.03	0.11	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	33.17	3.92	1.82	1.54	1.82	2.24	0.14	0.14	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	103.01	0.00	1.00	1.00	3.99	2.00	1.75	0.00	1.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	78.00	29.03	0.53	9.50	2.32	0.84	0.53	0.63	0.53	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	77.94	31.32	0.70	7.72	2.81	0.98	0.98	0.56	1.12	0.28
glioblastoma cell line:T98G	10485-107A8	21.74	1.10	0.44	1.55	1.66	0.33	0.00	0.00	0.00	0.00
glioma cell line:GI-1	10413-106B8	46.57	15.52	3.51	5.27	2.34	1.76	0.29	0.88	1.17	0.29
globus pallidus - adult, donor10196	10175-103C4	29.16	2.92	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	35.64	11.72	0.24	0.24	1.22	0.00	0.73	0.49	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	2.74	2.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	17.05	2.13	0.53	0.53	0.00	1.07	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	668.07	80.76	4.89	9.79	31.81	2.45	4.89	2.45	22.02	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	32.79	10.93	0.00	0.00	10.93	10.93	0.00	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	26.13	5.23	0.00	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	48.64	4.48	4.16	4.80	1.60	1.92	0.96	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	5.51	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	4.57	0.91	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	1.44	2.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	3.43	2.74	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	5.52	2.21	0.00	0.00	1.10	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	3.16	0.00	0.00	0.86	0.29	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	33.78	3.29	0.30	4.48	1.79	1.49	1.20	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	10.98	2.35	0.00	0.26	1.05	0.00	0.00	0.00	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	83.26	1.67	1.67	5.00	1.67	2.50	3.33	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	27.34	0.61	0.41	0.20	0.20	0.20	0.00	0.00	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	11.07	1.70	0.43	0.43	0.85	0.43	0.00	0.00	0.00	0.85
heart, adult, pool1	10016-101C7	7.36	1.38	0.23	0.69	0.46	0.00	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	8.83	3.18	0.21	0.41	0.21	0.10	0.00	0.00	0.00	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	107.37	0.31	6.48	5.24	4.01	5.55	0.00	0.00	1.54	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	21.41	0.00	0.00	0.00	4.76	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.74	0.00	0.11	0.66	3.87	0.11	0.99	0.00	0.22	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	32.16	0.00	0.12	0.61	2.55	0.00	0.36	0.00	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	29.81	0.00	0.10	1.21	2.63	0.10	0.91	0.00	0.20	0.00
hepatoma cell line:Li-7	10484-107A7	28.92	0.33	0.56	1.00	0.89	0.11	0.33	0.00	0.67	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	2.61	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	24.60	13.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	23.27	9.18	0.00	0.41	1.22	0.20	0.61	0.20	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	2.99	0.50	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	7.40	1.76	0.00	0.35	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	2.75	0.00	0.00	0.20	0.39	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	3.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.00	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	2.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	3.66	0.00	0.00	0.00	0.00	0.00	0.43	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.84	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	4.03	0.00	0.47	0.00	0.71	0.00	0.24	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.07	0.00	0.16	0.32	0.00	0.16	0.32	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.73	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	2.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.00	0.00	0.00	0.00	0.00	0.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	3.27	0.00	0.16	0.16	0.16	0.16	0.00	0.00	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	5.52	0.00	0.00	0.00	0.29	0.00	0.29	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.59	0.00	0.00	0.00	0.00	0.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.06	0.00	0.00	0.00	0.18	0.18	0.00	0.00	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.71	0.00	0.00	0.00	0.29	0.00	0.29	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	4.08	0.00	0.00	0.00	0.41	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1.76	0.00	0.00	0.00	0.35	0.00	0.35	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	0.63	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.14	0.00	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	3.32	0.00	0.00	0.66	0.00	0.66	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1.54	0.00	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.69	0.00	0.00	0.51	0.00	0.51	0.00	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1.51	0.00	0.00	0.76	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.11	0.00	0.34	0.00	0.34	0.34	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1.93	0.00	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	4.46	0.00	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.00	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	3.28	0.00	0.00	0.00	0.00	0.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	3.26	0.00	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	2.49	0.00	0.00	0.00	0.00	0.36	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	0.00	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	4.20	0.00	0.00	0.95	0.00	0.14	0.14	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	8.72	0.48	0.24	0.97	0.00	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	7.13	0.00	0.00	0.79	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	5.11	2.27	0.28	0.47	0.66	0.19	0.09	0.00	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	36.09	9.43	0.33	1.95	1.95	0.33	0.65	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	6.31	0.90	0.00	0.30	0.60	0.20	0.40	0.20	0.10	0.30
kidney, fetal, pool1	10045-101F9	9.12	1.70	0.14	1.06	0.71	0.21	0.14	0.00	0.07	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	92.03	37.21	7.53	2.70	3.83	3.41	0.57	1.28	1.99	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.26	0.00	0.00	0.28	0.41	0.14	0.00	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	72.85	27.71	0.55	0.92	0.37	1.10	0.73	0.18	1.28	0.37
left atrium, adult, donor1	10079-102A7	29.97	0.54	0.54	0.54	1.09	0.00	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	15.17	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	3.95	0.36	1.44	1.44	0.36	1.08	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	15.22	0.00	1.63	2.72	1.63	0.54	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	15.54	0.24	1.70	6.07	1.21	1.46	0.00	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	0.00	6.35	6.35	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	87.83	10.46	2.09	3.14	1.05	4.18	0.00	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	231.16	47.58	0.71	1.06	4.37	2.13	0.94	2.83	0.35	2.83
liposarcoma cell line:KMLS-1	10782-110G8	77.17	41.08	3.44	10.47	2.03	3.75	0.00	3.12	1.87	1.09
liposarcoma cell line:SW 872	10726-110A6	39.23	5.85	0.24	0.85	3.05	0.61	0.49	0.00	0.12	0.24
liver, adult, pool1	10018-101C9	9.40	0.16	0.16	0.32	0.32	0.65	0.32	0.00	0.00	0.32
liver, fetal, pool1	10086-102B5	12.23	1.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	24.21	5.83	0.29	0.58	0.73	0.15	0.58	0.00	0.00	0.58
locus coeruleus, adult, donor10252	10165-103B3	19.75	8.67	0.18	0.18	0.55	0.18	0.92	0.55	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	12.13	1.13	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	20.19	7.15	0.00	0.84	0.42	0.00	0.42	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	14.81	0.00	0.42	0.69	0.69	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	13.10	0.69	0.00	4.83	1.38	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	97.81	26.23	1.19	2.77	5.67	1.19	0.79	0.40	0.40	0.13
lung, adult, pool1	10019-101D1	47.96	5.43	2.01	6.26	2.13	1.54	0.59	0.95	0.47	0.71
lung, fetal, donor1	10068-101I5	40.53	5.71	0.00	22.26	3.42	2.85	10.85	1.43	1.71	0.86
lung, right lower lobe, adult, donor1	10075-102A3	69.19	7.33	0.46	3.67	0.46	0.92	0.46	0.92	1.37	0.92
lymph node, adult, donor1	10077-102A5	21.77	16.57	0.00	1.42	0.95	0.00	0.00	0.47	0.00	1.42
lymphangiectasia cell line:DS-1	10727-110A7	67.95	1.53	1.10	1.75	1.32	0.00	0.66	0.00	0.66	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	77.27	9.36	1.21	4.53	0.60	0.75	1.36	1.06	3.62	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	47.57	133.37	2.55	3.40	2.55	2.55	0.85	0.00	3.40	4.25
mature adipocyte, donor1	12231-129F8	66.15	0.00	2.22	4.44	0.89	3.11	0.44	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	33.83	0.00	1.87	3.74	0.62	1.25	0.83	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	40.30	0.24	2.37	3.56	0.47	2.84	0.24	0.00	0.71	0.00
mature adipocyte, donor4	12234-129G2	32.64	0.00	0.00	3.69	1.05	1.32	0.26	0.00	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	218.25	0.00	1.43	5.48	11.20	0.95	0.95	0.00	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	3.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	11.22	5.33	0.37	0.37	0.55	0.37	0.92	0.00	0.00	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	2.54	0.32	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	5.12	4.26	1.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	10.29	4.05	0.00	0.00	0.51	0.00	0.51	0.00	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	10.82	5.31	0.00	0.21	0.42	0.00	0.64	0.21	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	0.00	0.00	1.93	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.10	2.15	0.36	0.36	0.36	0.00	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	22.71	6.49	0.65	0.65	0.65	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	21.83	12.38	0.00	0.46	0.93	0.00	0.31	0.31	0.15	1.24
medulla oblongata, adult, pool1	10038-101F2	18.45	4.57	0.24	1.47	0.90	0.16	0.41	0.33	0.24	0.33
medulla oblongata, newborn, donor10223	10361-105F1	12.85	5.55	0.00	0.35	0.69	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	34.36	17.36	0.37	0.61	1.96	0.37	0.00	0.24	0.12	0.49
melanoma cell line:COLO 679	10514-107E1	38.96	0.00	0.29	1.15	2.73	0.14	0.14	0.00	0.29	0.00
melanoma cell line:G-361	10465-106H6	22.26	0.00	0.27	1.09	2.71	0.81	0.27	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	21.35	3.62	1.81	0.72	0.72	1.45	0.18	0.00	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.22	0.00	0.00	0.00	0.00	0.26	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	27.46	1.99	8.29	7.36	2.76	5.06	19.49	0.00	0.92	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	38.17	2.00	4.73	6.54	2.18	5.45	25.09	0.18	3.09	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	0.00	5.38	4.14	0.83	4.14	7.45	0.00	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	15.31	4.50	7.73	3.65	0.42	5.06	10.25	0.28	1.12	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	14.64	10.98	1.73	3.47	1.16	2.89	9.44	0.39	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	38.17	22.90	3.47	3.47	1.39	2.08	0.69	0.00	2.78	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.28	0.00	2.75	1.20	1.20	2.23	8.41	0.00	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.30	0.12	2.88	2.07	1.61	2.65	13.11	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	38.46	0.93	4.91	1.86	1.72	4.77	15.92	0.13	1.59	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.01	0.27	4.19	1.49	1.89	4.19	14.99	0.00	1.22	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	32.86	1.42	4.84	3.84	1.00	4.55	15.65	0.00	1.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	53.36	2.96	3.29	3.29	1.65	4.28	0.00	0.00	1.98	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.90	2.21	4.98	7.06	1.38	4.98	18.96	0.00	0.83	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	45.38	0.35	6.98	4.54	1.40	9.08	1.05	0.00	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.09	12.45	5.10	5.10	0.61	4.49	11.84	0.61	2.25	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.85	3.24	2.16	6.47	1.44	3.59	1.08	0.00	2.16	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	44.59	11.07	4.34	4.45	1.45	5.59	22.45	1.45	1.86	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.23	6.16	2.74	6.61	0.46	1.82	0.68	0.00	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	25.17	13.43	11.33	6.29	0.42	6.29	17.20	0.42	1.68	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.24	0.45	10.31	6.43	1.64	5.38	15.39	0.00	1.94	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	28.10	11.82	4.38	3.76	0.88	4.38	17.51	0.70	1.40	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	67.74	0.37	6.63	2.21	3.68	6.63	0.00	0.00	3.31	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	60.38	4.58	6.58	10.30	1.72	4.86	1.14	0.00	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	38.73	87.15	4.21	5.05	0.42	2.95	0.42	2.95	1.68	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	34.71	0.91	0.91	1.37	1.37	0.91	0.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	31.97	1.02	2.81	3.84	4.60	1.02	0.77	0.00	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	33.77	0.79	1.57	3.93	3.93	0.52	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	33.27	2.46	1.23	1.54	2.46	2.16	0.62	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.95	0.94	2.12	3.29	2.82	1.18	1.18	0.00	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.78	0.34	1.02	5.42	2.71	1.35	0.00	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.36	0.79	1.18	5.89	3.54	1.18	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.22	2.78	0.93	2.32	2.78	0.46	1.39	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.90	1.44	2.88	4.04	2.88	2.31	0.58	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	26.33	2.23	1.34	3.12	3.57	1.56	0.22	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.31	0.96	0.96	2.64	2.16	2.16	0.72	0.00	0.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.87	3.67	0.00	0.73	4.40	0.73	1.47	0.00	2.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.49	2.01	1.01	2.69	3.02	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	0.41	0.00	2.87	1.64	1.64	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.19	2.58	0.86	2.58	2.58	3.44	0.86	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	2.73	0.00	2.73	0.00	0.00	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	0.00	0.00	0.00	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.11	0.65	0.32	2.92	2.27	0.65	0.65	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	0.00	1.45	2.91	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	41.58	0.53	0.53	2.13	2.13	1.07	0.53	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	27.80	0.00	0.82	1.64	3.27	0.82	0.00	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.99	1.17	0.00	1.94	2.72	0.78	1.17	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	0.00	6.30	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	0.99	0.99	0.99	2.98	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	4.77	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	24.31	0.00	0.00	2.37	0.59	0.59	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	31.68	0.00	1.22	1.22	0.00	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	27.24	0.00	0.63	0.00	1.90	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.25	0.00	1.03	2.07	0.69	0.34	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	0.00	0.00	4.30	0.00	0.00	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	16.30	0.00	0.00	0.81	1.22	0.41	0.00	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.92	1.59	0.00	0.79	0.79	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	0.59	0.00	0.00	0.00	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.09	0.00	0.00	0.31	0.31	0.00	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	0.00	0.00	1.34	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	1.18	1.18	0.00	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	2.57	0.00	0.00	0.00	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	0.00	1.38	0.69	0.00	0.00	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.42	0.49	0.00	0.00	0.49	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	0.00	0.00	0.00	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.06	0.00	0.00	0.00	2.01	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	0.00	0.00	0.00	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	0.00	0.00	0.00	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	6.59	0.00	0.00	0.00	2.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.22	0.00	0.40	0.79	0.60	0.00	0.79	0.00	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.60	0.00	0.00	0.97	0.97	0.32	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	0.00	0.00	0.00	2.04	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	4.64	0.00	1.55	2.32	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	49.61	0.24	0.94	1.65	1.89	1.89	0.94	0.00	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	58.85	0.00	0.93	0.23	0.23	0.46	1.39	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	25.64	0.00	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	19.52	12.95	1.13	1.75	0.10	1.03	0.00	0.00	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	35.40	1.36	0.23	2.72	2.27	0.23	0.00	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	35.45	7.09	0.98	1.96	1.96	1.71	0.98	0.49	0.24	0.98
mesothelioma cell line:Mero-48a	10852-111F6	33.88	11.29	0.44	2.21	1.33	0.00	0.44	0.44	0.22	0.89
mesothelioma cell line:Mero-82	10853-111F7	37.06	3.42	0.53	4.20	1.58	0.79	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	43.92	18.89	0.68	4.09	1.87	0.51	0.51	0.34	0.34	0.51
mesothelioma cell line:Mero-84	10855-111F9	10.62	0.76	0.00	1.01	0.51	0.00	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	36.23	21.53	0.21	1.04	2.28	0.41	0.21	0.00	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	57.48	15.74	1.99	1.82	1.16	1.16	0.83	0.00	0.00	1.99
mesothelioma cell line:NCI-H226	10846-111E9	30.77	0.00	2.17	1.99	2.17	1.09	0.00	0.00	0.54	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	19.64	0.00	0.17	2.73	2.05	0.68	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	8.91	1.02	0.00	2.04	0.51	0.00	0.00	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	11.74	0.00	0.00	1.30	3.59	0.00	0.65	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	22.22	3.52	0.27	1.63	0.27	0.27	0.27	0.00	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	3.84	0.38	0.38	0.58	0.38	0.19	0.00	0.19	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	1.71	0.24	0.12	0.00	0.00	0.12	0.00	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	1.97	0.00	0.00	0.18	0.36	0.00	0.18	0.18	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	8.81	0.98	0.65	2.61	0.33	0.33	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.06	2.54	0.64	0.00	0.21	1.27	0.00	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	102.05	53.67	0.46	0.92	3.92	0.46	0.92	0.00	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	53.09	2.66	0.00	2.66	2.85	0.57	0.19	0.95	0.95	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	169.64	62.83	4.44	3.88	3.70	1.48	1.48	0.74	1.66	1.48
myeloma cell line:PCM6	10474-106I6	21.15	15.62	0.40	0.40	4.15	0.00	0.40	3.16	0.00	2.37
myxofibrosarcoma cell line:MFH-ino	10600-108E6	20.80	4.06	0.51	1.52	2.03	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	108.27	0.78	11.77	2.94	4.71	4.90	1.18	0.00	0.39	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.28	0.56	0.33	1.00	1.78	1.11	0.45	0.00	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.22	0.22	0.37	0.59	1.47	1.25	0.22	0.00	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	50.23	24.84	3.31	2.76	6.07	1.10	0.55	1.66	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	0.69	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	5.43	0.00	0.00	2.25	1.68	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	8.76	0.00	0.00	0.56	1.49	0.19	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	64.68	0.53	3.99	3.19	2.93	2.66	0.27	0.00	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	79.68	0.00	0.00	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	340.27	282.77	1.01	10.99	3.38	0.34	2.03	5.58	1.86	9.64
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	0.00	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	83.04	0.00	8.66	4.81	1.60	5.45	0.64	0.00	3.53	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	43.62	5.52	3.94	5.52	0.79	1.58	0.79	0.00	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	5.81	1.50	0.00	0.47	0.09	0.09	0.09	0.09	0.19	0.00
occipital cortex - adult, donor10196	10172-103C1	8.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	19.32	7.78	0.00	0.54	0.54	0.00	0.81	0.00	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	10.19	2.91	0.00	0.36	0.00	0.36	0.00	0.36	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	3.15	3.41	0.00	0.52	1.31	0.00	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	2.15	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	2.13	0.87	0.08	0.00	0.24	0.00	0.08	0.00	0.08	0.08
olfactory region, adult	10195-103E6	4.59	1.91	0.00	0.19	0.00	0.00	0.19	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	14.01	2.00	0.00	0.00	0.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.25	34.17	3.30	0.68	0.80	1.82	0.46	1.25	0.57	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	68.69	17.04	0.82	0.82	1.79	0.82	0.55	0.00	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	19.13	16.93	0.34	0.17	0.85	0.51	0.34	0.17	0.68	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	53.13	40.54	1.73	1.04	3.81	1.27	1.62	0.23	0.69	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	52.91	9.41	1.18	5.59	1.76	1.76	0.00	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	59.80	4.67	12.15	7.47	7.47	3.74	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	1.06	0.00	0.00	0.21	0.42	0.00	0.00	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	18.69	1.14	0.26	3.76	2.27	0.70	0.09	0.35	0.26	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	51.51	0.55	2.93	4.77	1.28	3.48	0.73	0.18	1.10	0.00
pancreas, adult, donor1	10049-101G4	19.75	0.94	0.00	0.94	0.94	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.66	0.00	0.00	1.68	2.80	0.28	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	53.83	104.77	2.04	2.90	0.85	0.51	1.02	0.51	0.34	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	94.22	94.88	7.12	1.49	2.15	2.48	0.33	1.16	1.49	2.48
paracentral gyrus, adult, pool1	10035-101E8	4.67	1.74	0.00	0.18	0.27	0.18	0.00	0.00	0.00	0.27
parietal cortex, adult, donor10258	10373-105G4	14.68	1.47	0.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	2.82	0.00	0.00	0.94	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	9.41	2.57	0.29	0.29	0.00	0.29	0.57	0.57	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	4.32	2.64	0.00	0.26	0.26	0.00	0.00	0.00	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	1.94	1.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.96	1.87	0.37	0.37	0.37	0.37	0.37	0.00	0.00	0.00
parotid gland, adult	10199-103F1	13.57	3.08	0.00	1.85	1.85	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	17.19	1.07	0.54	3.76	1.07	0.54	1.61	0.00	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	67.60	3.21	0.58	2.19	1.89	1.17	0.58	0.00	1.02	0.15
pineal gland - adult, donor10196	10179-103C8	12.26	2.58	0.00	1.94	0.00	0.00	0.65	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	20.73	2.96	0.59	0.59	0.59	0.00	0.00	0.00	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	2.51	0.00	0.00	0.63	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	19.22	0.00	0.00	3.04	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	44.82	1.56	0.00	1.04	1.04	0.00	0.52	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	5.96	0.85	0.00	0.85	0.00	0.00	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	19.67	1.83	0.43	1.83	1.51	1.18	0.00	0.22	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	19.86	8.87	0.13	1.32	0.79	0.26	0.13	2.38	0.93	2.91
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	56.65	6.69	4.05	1.40	0.93	1.56	0.62	0.00	0.93	0.00
pons, adult, pool1	10033-101E6	7.83	3.70	0.17	0.60	0.43	0.00	0.09	0.09	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	2.96	1.39	0.00	0.17	0.26	0.09	0.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	20.91	0.00	2.09	14.64	0.00	0.00	0.00	2.09	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	22.03	0.00	0.00	5.51	0.00	0.00	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	63.36	8.45	2.48	2.33	2.91	1.46	1.02	0.15	1.17	0.00
prostate cancer cell line:PC-3	10439-106E7	73.69	11.98	3.27	3.09	4.72	1.82	0.36	0.54	0.91	0.36
prostate, adult, pool1	10022-101D4	27.75	2.27	0.45	2.09	2.18	0.54	0.27	0.45	0.09	0.09
putamen, adult, donor10196	10176-103C5	12.51	4.25	0.47	0.00	0.24	0.47	0.24	0.00	0.24	0.00
putamen, adult, donor10252	10152-102I8	17.65	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	1.09	2.19	0.00	0.00	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1.45	0.48	0.00	0.00	0.24	0.00	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	10.50	7.50	1.50	0.00	0.00	0.00	0.00	0.00	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	111.43	0.00	0.29	5.82	9.89	0.58	1.45	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	36.17	1.39	0.00	4.17	6.95	0.00	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.01	12.51	3.18	2.33	1.70	2.12	0.21	0.42	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.23	12.43	2.07	6.21	1.24	1.66	0.83	1.66	0.83	0.00
retina, adult, pool1	10030-101E3	14.02	2.98	0.10	0.30	1.39	0.20	0.30	0.60	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	6.19	2.53	0.00	0.00	1.69	0.00	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	72.00	0.76	0.76	4.55	6.06	2.27	0.00	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	22.98	1.46	0.81	2.43	1.78	0.81	0.16	0.00	0.00	0.32
salivary acinar cells, donor2	11772-123I8	28.09	0.14	1.10	4.54	1.10	1.38	0.14	0.00	0.69	0.00
salivary acinar cells, donor3	11773-123I9	39.72	0.00	0.66	3.31	1.99	1.32	0.66	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	20.02	1.72	0.57	4.00	1.14	1.14	5.15	0.57	2.29	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.01	3.96	4.22	4.72	3.63	2.53	0.42	0.08	0.51	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	28.57	3.53	5.05	3.17	4.11	2.35	0.12	0.12	0.82	0.12
seminal vesicle, adult	10201-103F3	29.10	3.17	0.00	3.17	3.70	1.59	0.53	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	71.66	9.96	0.73	1.21	1.70	2.43	0.97	0.00	1.46	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.19	2.26	2.26	6.54	0.75	1.51	0.75	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	6.02	1.00	5.02	2.01	3.01	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	13.03	0.27	0.00	0.94	2.01	0.13	0.00	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	79.25	120.81	0.44	0.66	1.44	0.44	1.11	2.10	0.22	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	18.45	0.00	0.13	0.77	3.23	0.13	0.00	0.00	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	18.44	17.73	0.71	1.42	1.42	0.71	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	30.70	14.99	1.56	3.72	1.56	1.68	0.48	0.60	1.32	0.00
skeletal muscle, fetal, donor1	10066-101I3	11.06	0.00	0.00	0.00	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	92.16	8.84	0.00	6.31	7.57	1.26	0.63	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.36	0.00	0.33	0.67	2.67	0.00	0.33	0.00	0.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	51.38	1.58	0.00	2.21	4.10	0.32	0.32	0.00	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	200.59	49.61	0.82	6.10	5.60	0.66	1.15	2.14	0.66	0.82
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.32	0.00	0.00	0.00	0.32	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	20.92	18.52	0.22	0.65	0.87	0.00	0.00	0.00	0.44	0.22
small intestine, adult, pool1	10024-101D6	18.87	2.75	0.36	1.19	3.58	0.12	0.48	0.36	0.12	0.60
small intestine, fetal, donor1	10064-101I1	15.48	3.44	0.00	2.95	2.70	0.00	0.98	0.00	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	17.44	0.00	0.00	1.03	0.51	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	13.70	2.07	0.00	0.78	1.03	0.26	0.26	0.00	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	22.51	0.00	0.00	0.00	2.68	0.00	0.27	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	44.05	11.93	0.23	0.69	0.23	0.23	0.92	0.00	0.92	0.23
spinal cord, adult, donor10252	10159-103A6	42.19	16.56	0.00	0.00	2.76	0.00	0.39	1.97	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	8.30	1.38	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	10.98	3.05	0.00	2.44	1.22	0.00	0.00	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	25.26	12.86	0.46	0.46	0.00	0.46	0.00	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.65	4.33	2.69	5.82	3.58	2.69	0.30	0.30	0.60	0.30
spleen, adult, pool1	10025-101D7	19.93	13.66	0.88	1.54	1.32	0.44	0.88	1.98	0.11	0.44
spleen, fetal, pool1	10044-101F8	18.20	20.42	0.56	2.07	2.15	0.40	0.08	1.03	0.56	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.21	0.00	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.23	7.97	0.38	1.90	2.66	0.57	1.33	0.19	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.80	0.35	0.00	1.05	2.10	0.00	0.00	0.00	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	61.77	28.93	1.56	2.35	2.35	2.74	1.17	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	39.73	35.91	1.58	0.45	2.14	0.90	0.45	1.35	0.56	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.64	0.00	0.00	0.00	1.69	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	15.23	4.23	0.00	1.69	2.96	0.85	0.00	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	95.05	3.20	0.00	2.14	6.41	2.14	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	26.21	13.10	0.00	0.57	2.85	0.00	1.71	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	26.38	12.46	0.21	0.42	1.04	0.62	0.42	0.42	0.00	0.42
substantia nigra, adult, donor10258	10371-105G2	4.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	15.54	5.65	0.00	0.71	0.71	0.71	1.41	0.00	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.95	0.00	0.23	2.98	0.69	0.00	0.00	0.00	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	2.97	1.19	0.00	0.17	0.08	0.08	0.08	0.00	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.96	1.76	0.00	0.44	0.00	0.00	0.00	0.44	0.00	0.44
tenocyte, donor1	11763-123H8	43.64	8.03	2.79	1.75	2.09	3.14	0.70	0.00	0.70	0.35
tenocyte, donor2	11765-123I1	83.55	27.47	0.38	2.67	2.29	1.53	0.76	2.29	0.76	0.38
tenocyte, donor3	11768-123I4	17.05	1.11	1.48	2.59	0.74	2.59	0.00	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.16	0.34	0.00	0.68	2.21	0.34	0.34	0.00	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	33.91	0.31	0.46	1.08	2.31	0.00	0.00	0.00	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	1.55	0.00	0.00	0.00	0.31	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	5.46	0.00	0.00	0.25	0.51	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	6.43	0.00	0.00	3.03	5.29	0.38	0.38	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.42	0.11	0.00	2.94	0.44	0.00	3.05	0.00	0.22	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	11.92	1.72	0.86	2.04	0.64	0.64	0.11	0.21	0.11	0.00
testis, adult, pool2	10096-102C6	11.28	1.35	0.00	0.90	0.45	0.00	0.45	0.00	0.00	0.00
thalamus - adult, donor10196	10168-103B6	20.98	6.62	1.10	0.00	1.10	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	21.10	12.97	0.00	0.47	1.25	0.31	0.63	0.16	0.16	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	3.08	0.00	0.00	0.00	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.76	1.81	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	5.18	1.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	32.46	9.24	0.50	3.25	2.25	0.25	0.25	0.50	0.50	0.50
throat, fetal, donor1	10061-101H7	39.31	5.18	0.00	0.91	2.13	0.61	0.00	0.30	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	2.98	0.20	0.00	0.00	0.99	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	25.15	198.93	0.30	2.58	1.09	0.10	0.10	3.18	1.09	7.85
thymus, fetal, pool1	10043-101F7	33.77	207.08	0.73	3.22	2.39	0.31	0.21	3.22	0.73	7.69
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.32	3.46	1.46	3.32	1.73	1.33	0.80	0.27	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	37.58	11.73	1.82	4.47	1.96	0.56	0.28	0.00	0.70	0.14
thyroid, adult, pool1	10028-101E1	9.80	1.03	0.00	0.19	0.56	0.09	0.09	0.00	0.00	0.00
thyroid, fetal, donor1	10060-101H6	10.02	2.64	0.00	0.26	1.32	0.00	0.00	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	6.16	0.00	3.08	0.00	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	15.82	2.09	0.23	1.86	1.16	0.23	0.23	0.23	0.70	0.23
tongue, fetal, donor1	10059-101H5	17.34	0.79	0.00	0.39	0.39	0.39	0.00	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	25.54	29.65	0.30	0.70	2.50	0.60	0.40	5.01	0.40	2.91
trachea, adult, pool1	10029-101E2	100.12	3.76	1.47	8.59	4.74	1.80	1.23	0.33	1.55	0.16
trachea, fetal, donor1	10058-101H4	89.63	2.69	0.38	4.23	3.08	0.77	0.77	0.00	1.54	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.49	0.35	2.48	9.57	2.48	2.13	1.06	0.00	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	135.66	93.11	7.19	3.44	2.74	2.74	1.01	1.11	1.52	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	63.77	67.06	2.98	4.54	3.60	2.35	0.78	2.04	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	93.22	0.00	3.81	3.81	5.71	0.00	1.90	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.14	0.59	0.59	1.19	1.10	0.42	0.08	0.08	0.25	0.00
umbilical cord, fetal, donor1	10057-101H3	33.38	2.09	0.00	0.00	4.17	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	7.85	3.24	0.34	1.71	1.02	0.00	1.88	0.51	0.17	0.51
uterus, fetal, donor1	10055-101H1	34.81	2.56	0.00	1.02	1.02	0.00	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	23.26	0.00	0.65	1.29	0.00	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	13.59	30.25	0.00	1.75	0.44	0.00	0.22	1.32	0.44	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1.34	0.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "BC110828:-160 KF041488:-214 AK226159:-250 BC136381:-341 BC144053:-341 BC136380:-341 KJ189471:-418 KJ189464:-418 ENST00000416754.1:-446 X90979:-446 AK310587:-463 ENST00000482318.5:-464 D89788:-464 D89789:-464 D89790:-464 ENST00000437180.5:-474 ENST00000455571.5:-474 ENST00000675419.1:-478 NM_001754.5:-478" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.